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ABSTRACT

Protein-protein interactions (PPI’s) play important roles in biological systems.

In

particular, intra-protein interactions help create and maintain correctly folded protein states and
mutations that result in misfolded states may be associated with significant changes in PPI
behavior. Six unrelated protein systems with known structure files, each consisting of a wild-type
and mutant strain, were studied using the computational algorithm OpenContact©. OpenContact©
is a simple tool that can be used to rapidly identify or map interactions “hot-spots” in a protein and
was, consequently, used in this study as a starting point to examine the potential or possible role
of PPI’s on the behavior of mutated, misfolded proteins. Specific results include the observations
of single chain protein systems exhibiting mutant strains with significantly stronger inter-atomic
interactions as well as a surprising gain of secondary structure in the mutant state. These
observations stood in contrast to multi-chain systems (proteins with more than two constituent
chains) that appeared to display stronger inter-atomic interactions for the wild-type strains. Results
also indicated a potential classification scheme for intra-protein interaction behavior in mutated
states based on several criteria. It is important to note, however, that observations on PPI behavior
presented need to be verified across a greater number of systems than those studied here before
any such trends can be concretely established.

1.0 INTRODUCTION

Proteins are important and extremely vital components of every organism on the planet.
Their functions can range from structural support, to membrane transport, metabolism, cell cycle
control, and many others. It is therefore not surprising that serious health problems can manifest
themselves should there be an aberrant expression of any protein such that its role and function
are impaired, or altogether eliminated. Although it is even possible that the novel form of the
protein may incur beneficial effects to its host, these events are rare and the more prevalent
scenario of aberrant protein expression is the manifestation of disease states. It is therefore
beneficial to consider the implications incumbent on mutations that result in misfolded proteins
expressed differently from their natural or “wild-type” design. Although mutations of any sort
are not to be trivialized, the main class of mutations whose negative effects are to be considered
in this work are inherited missense mutations that lead to congenital disease.

By contrast, mutations incurred throughout an organism’s lifetime typically affect cell
growth and development which can lead to cancer. These two holistic manifestations of disease
between inherited and acquired mutations are ultimately different in how they affect the whole
organism. Although both can pose life-threatening scenarios, the treatments and considerations
for each require different approaches despite the fact that mutations fundamentally lie at the heart
of both scenarios. As an example of the unique consequences of genetic damage that can lead to
acquired mutations, one can turn to observations in the medical literature that document certain
classes of tumors (i.e. ovarian, colorectal, renal, etc…) being associated with genetic damage to
specific genes (Gao, Aksoy, Dogrusoz & et al., 2013). For aberrant proteins resulting from
inherited mutations, the approach to disease study and pharmaceutical development generally
1

rests on understanding how the protein’s structural differences between the wild-type and mutant
strains results in said protein’s new bio-chemical and biophysical properties that effectively leads
to disease (Jorgensen, 2004). This is the approach that served as the foundation and perspective
for the study that was undertaken for this thesis.

2.0 BACKGROUND AND SIGNFICANCE

There exists a plethora of human disorders based on incorrectly folded proteins. Whether
one considers disorders as well-known as Cystic Fibrosis and Lou Gehrig’s disease or more
obscure maladies such as Tay-Sach’s disease and Fatal Familial Insomnia, the underlying mode
of biological sabotage remains the same: a protein or enzyme is misfolded due to a hereditary
missense mutation or an acquired mutation that results in said protein or enzyme either losing its
wild-type (and necessary) biological activity or gaining some activity detrimental to biological
function (Reynaud, 2010). As alluded to earlier, the importance of proteins in biological systems
is immense. In single celled organisms, they can be responsible for anything from membrane
transport to digestion (save for autotrophic systems such as euglenas) to even motility (the
archetype of which are the cilia of paramecia or the flagella of Helicobacter pylori) (Lefebvre,
2001). In viruses, proteins are responsible for reproduction regardless of viral classification
(adenoviruses or retroviruses) and most notoriously of all, proteins are essential for host cell
entry for all viral classes. In plants, proteins play an important role in embryonic development in
spermatophyte species (Soltis, Soltis, & Zanis, 2002). Their importance is even more varied in
complex multi-cellular organisms where proteins can play crucial roles in immunization, oxygen
transport, structural support and even chemical defense for venomous and poisonous species.
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Given the interplay, balance and dependence that many of these systems have with one
another for multicellular organisms, one can quickly see that an interruption to any one
component can have devastating domino effect-like consequences for the whole organism.
Although the results of one system may not directly impact another by providing a bio-chemical
product for subsequent use in the next biological process stream, impairing any biological
function will place additional strain on any peripheral systems. This strain can be inconvenient
at best, or life-threatening at worst. Thus, the importance for quantifying and thoroughly
understanding these misfolding events is absolutely necessary to gain appreciation for the states
of health and the treatment of disease.

2.1 IN HUMANS: A CLOSER LOOK

In human systems, missense congenital mutations can lead to a variety of disorders that
can affect a wide range of life support systems. As an example, Cystic Fibrosis results from a
mutation in the gene Cystic Fibrosis Transmembrane Conductance Regulator (CFTR gene)
which ultimately leads to an improperly folded version of its respective protein that bears the
same name: the CFTR protein (Andersen, 1938). Under wild-type circumstances, this transmembrane cellular protein is responsible for the regulation of components in sweat and digestive
fluids but more importantly, it is responsible for the movement of sodium and chloride ions
across the membranes of epithelial cells such as the alveolar epithelia lining of the lungs as well
as that of the pancreas and intestines (Andersen, 1938). When a mutation occurs, this function is
severely impaired if not eliminated (depending on the actual mutation) and leads to the thick
mucus buildup in the lungs characteristic of cystic fibrosis. Cascade events such as pulmonary
infections, trouble breathing and poor oxygen delivery can then result complicating matters
3

further for the patient. As of 2008, the median age of survival in the United States for this
disease is 37 years (Andersen, 1938).

Missense mutations that lead to diseases such as cystic fibrosis are not just limited to
pulmonary epithelial cells, they can also strike and affect proteins critical to the central nervous
system. In Tay-Sach’s disease, a mutation on the HEXA gene (which codes for
hexosaminidase’s, alpha, or “A” subunit) results in a defective version of the enzyme dimer
complex, hexosaminidase (the hexosaminidase dimer has an alpha and a beta subunit) (Clarke,
Mahuran, Sathe, & et al., 2004). With the alpha or HEXA subunit improperly folded, the entire
enzyme is rendered inoperative and incapable of executing its function: degrading ganglioside
molecules from propagating ganglion cells of the brain (Clarke et al.). With these molecules
rapidly accumulating, they ultimately take on toxic properties that lead to the premature death of
the brain’s nerve cells (Clarke et al.). The progressive deterioration of these cells results in a
decline of mental and physical abilities that can start as early as six months of age in patients
suffering from the infantile form the disease (Clarke et al.). Examples of functions that are
eventually lost are swallowing and breathing (Clarke et al.). As there is no cure for Tay-Sach’s
disease, the ultimate prognosis is death which is around four years of age for sufferers of the
infantile version but can be variably longer for sufferers of the late onset forms of this disorder
(Clarke et al.).

Although the negative effects of misfolding events due to mutations has been strongly
emphasized and illustrated up to this point, it is important to keep in mind that not all mutations
result in entirely negative consequences for the carrier. A very interesting example that
illustrates this is the mutation known as CCR5 delta 32. This mutation results from a deletion of
4

32 base pairs on a gene known as the CCR5 gene that is normally responsible for expressing the
CCR5 protein on the surface of white blood cells such as T cells, macrophages and dendritic
cells (Buseyne, Janvier & Teglas, 1998). Under normal circumstances, this cellular surface
protein is responsible for serving as a receptor cite for chemokines during immune and immunerelated inflammatory responses. When the deletion mutation manifests itself however, the CCR5
protein either fails to be expressed, or is expressed in considerably lower quantities (Buseyne et
al., 1998). This has considerable ramifications for viruses that may make use of the CCR5
receptor protein to gain entry into their host cells. HIV is the quintessential virus that wreaks
havoc through the CCR5 cellular receptor and those individuals who manifest the mutation either
have total immunity to HIV or are able to maintain the viral population at considerably low
levels (these specific individuals are known as long-term-nonprogressors or elite controllers)
(Buseyne et al., 1998). Due to the inherited genetic nature of this mutation, replicating these
altered white blood cells are of active interest in the gene therapy community. The importance of
this case serves to establish and emphasize the point that although genetic mutations leading to
misfolded or entirely absent proteins can lead to disease, they can confer a genetic advantage if
the mutation occurs at the right place and time.

3.0 RESEARCH OBJECTIVES

For the content of this thesis, a total of six misfolded protein cases, or systems, were
selected, in part, based on the availability of molecular structure files for both wild and mutant
forms of the same protein. Systems containing mutations affecting cysteine residues which
would result in the disruption of intra-protein disulfide bridges and, consequently,
dramatic/obvious structural changes were purposefully omitted from this study. Each one of the
5

six cases were identified from the literature and separately analyzed. Each system analyzed was
therefore comprised of two protein structure files: a wild type protein structure file and a mutant
version of the same protein. As in the foregoing general examples of diseases stemming from
protein misfolding, the six systems analyzed for this project also resulted in disease states, but
unlike the examples mentioned above, many of the actual systems’ respective maladies
considered for this project are not as well documented or studied due to the fact that they are not
as prevalent or the necessary structure files have only been recently determined.

The overall goal and objective of the research reported here was to identify and quantify
the differences in the intra-protein interactions between a wild type protein and a mutant version
of that same protein. Consequently, the scope of this project was solely at the intra-protein level.
The strategy for determining these differences was via a computational approach based on
mapping of the inter-atomic potential field using AMBER 03 force field model. Initially, it was
thought that the mutant version of the protein would generally exhibit weaker intra-molecular
interactions and a loss of structure compared to the wild type version of the protein.
Interestingly, although some systems did exhibit this trend, this was not always the case. Two
pieces of software were particularly useful and instrumental in reconciling this information:
OpenContact© and DS-Viewer Pro®. OpenContact© provided the computational data and
mathematical models surrounding the inter-atomic forces, interactions and distances within each
protein that was analyzed. DS Viewer Pro in turn provided qualitative structural visualization
images for each protein. In all, data for each system thus consisted of numerical data for the
binding parameters analyzed as well as visual molecular images detailing the differences in
tertiary and quarternary structure between each case’s wild-type and mutant strains.
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3.1 MOLECULAR MECHANICS: FOUNDING PRINCIPLES

The computational criterion for quantitatively determining the interatomic attractions and
forces is founded on the discipline of molecular mechanics. Molecular mechanics is an
application of classical mechanics (or Newtonian mechanics, the most common branch of
physics) to model the movement of the individual atomic constituents in molecular systems
(Kuhn, Kollman, & et al., 2000). This discipline is used to study a wide range of chemical
species behavior ranging from small organic molecules containing only a few atoms, to large
biological macromolecules such as proteins and DNA which may contain anywhere from several
thousand to several million atoms. As alluded to earlier, the calculations that provided the
quantitative data for this project were ultimately executed by OpenContact©, a computer
algorithm, but the fundaments of the underlying code are all based upon what follows in this
section and needless to say, the calculations are performed by the algorithm for as many atoms
that are present in the system being analyzed.

In its most basic manifestation, molecular mechanics models systems via an “all-atom”
approach: each individual atom in the molecule is treated as a single particle (Kuhn et al., 2000).
Each particle in turn, is then assigned a radius (most typically the van der Waals radius), along
with a variety of different parameters that account for polarizability, constant net charge and
bond angles (more on these parameters later) (Kuhn et al., 2000). The bonded interactions are
modeled as stiff mechanical springs with an equilibrium distance equal to the experimental or
calculated bond length (Kuhn et al., 2000). As will be explored in greater detail shortly, the
particular force field parameters assigned to each atom follow from large scale quantum
mechanical calculations. Note that there are additional variations of this paradigm in use such as
7

the “united-atom” model, which treats each terminal methyl group or intermediate methylene
unit as a single particle, and the so-called “bead” model which assigns two to four particles to an
individual amino acid in a protein system (Kuhn et al., 2000). It is the “all-atom” model
however that finds use in this project via the OpenContact© software and, thus, the data that
follows in the coming sections is entirely from an atomic perspective.

Now that the modeling technique has conceptually been defined, it is appropriate at this
point to specifically detail the mathematical treatment of the “all-atom” model or potential
function. From a mathematical and physical perspective, the molecular mechanics calculations
are based simply a summation of a variety of different potentials inherent in a molecular system.
The two most fundamental categories of these potentials are the collective potentials governing
covalent bonding between atoms and the collective potentials governing non-covalent bonding
(i.e. electrostatic attractions). These two master families (covalent and non-covalent) are then
added together to give the total potential energy of the molecule under study. Therefore
mathematically the functional form of the potential function is (Kollman, Massova, Reyes, & et
al., 2000),

(1) 𝐸𝑇𝑂𝑇 = 𝐸𝐶𝑂𝑉𝐴𝐿𝐸𝑁𝑇 + 𝐸𝑁𝑂𝑁−𝐶𝑂𝑉𝐴𝐿𝐸𝑁𝑇

where the covalent term is,

(2) 𝐸𝐶𝑂𝑉𝐴𝐿𝐸𝑁𝑇 = 𝐸𝐵𝑂𝑁𝐷 + 𝐸𝐴𝑁𝐺𝐿𝐸 + 𝐸𝐷𝐼𝐻𝐸𝐷𝑅𝐴𝐿

and the non-covalent term is,
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(3) 𝐸𝑁𝑂𝑁−𝐶𝑂𝑉𝐴𝐿𝐸𝑁𝑇 = 𝐸𝐸𝐿𝐸𝐶𝑇𝑅𝑂𝑆𝑇𝐴𝑇𝐼𝐶 + 𝐸𝑉𝐴𝑁 𝐷𝐸𝑅 𝑊𝐴𝐴𝐿𝑆

Eqs. (2) and (3) contain some of the potentials briefly mentioned in the foregoing paragraphs and
we now see where and how exactly these potentials are prescribed in the grand scheme of
molecular mechanics calculations.

Each term in Eqs. (2) and (3), in turn, are defined according to specific potential models.
Starting with Eq. (2) (modeling covalent bonding), the bond and angle terms (EBOND and EANGLE)
are typically modeled as harmonic potentials centered about equilibrium bond length values.
This approach makes use of the classical setup commonly seen when analyzing the equations of
motion for periodically occurring phenomena such as a swinging pendulum or (as is most
appropriate in the present case of a chemical bond) a spring rapidly expanding and contracting.
Such a harmonic potential may therefore be of the form,

(4) 𝑥(𝑡) = 𝐴𝑐𝑜𝑠(𝜔𝑡 + 𝜙)

where,

𝑘 2𝜋
𝜔=√ =
𝑚
𝑇

which would represent the angular frequency of bond vibration. The dihedral term in Equation 2
(EDIHEDRAL) is modeled with the appropriate potentials, but they tend not to be harmonic
oscillators and their various functional forms tend to vary with the specific implementation of the
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potential function. Improper dihedral mathematical models may be included to enforce the
planarity of aromatic rings and other conjugated systems.

For the non-covalent interactions considered in Eq. (3), the electrostatic term
(EELECTROSTATIC) takes into account any inherent charges possessed by the constituent atoms of the
protein due to electron deficiencies or excesses as well as dipole, quadrapole, or higher moments
due to shifting electron positions. It is modeled with Coulomb’s law for two point charges
(Peters, 2007),

(5) 𝑢(𝑟) =

𝑞1 𝑞2
𝑟

where q1 and q2 are the charges of each point and are given in electrostatic units (1 esu ≡ 1
dyne1/2▪cm). The van der Waals term (EVAN DER WAALS) in Equation 3 further considers BOTH the
short range (Born) repulsive forces and the longer-range (van der Waals) attractive forces present
at the intermolecular level (Peters, 2007). These forces, although similar in concept to the
electrostatic forces previously mentioned, primarily differ in the sense that van der Waals forces
are associated with oscillating, time-dependent electric fields created by the wave, or
probabilistic behavior, of electrons in atoms (by themselves, van der Waals forces are
mathematically modeled as r-7 where r is the separation distance between the two species)
(Peters, 2007). This is in distinction to the more fixed nature of positive or negative charge that
is modeled by Coulomb’s law. Although the term in Eq. 3 primarily bears the name van der
Waals, it is important to note that the specific potential function actually used incorporates both
Born and van der Waals repulsions and attractions respectively. On the atomic scale, the precise
nature of Born repulsive forces manifest themselves when two atoms (or molecules) approach
10

each other at distances slightly larger than σ where σ is the atomic or molecular diameter. At
these very small separation distances, the electron shells of the two molecular (or atomic) species
partially penetrate each other (Peters, 2007). The nuclei of the constituent atoms (which are
positively charged) are now no longer shielded by their respective electron shells and so they
now repel one another. It is important to note that the scenario of Born repulsion, despite the
physical similarities with covalent bonding, differs from covalent bonding in that no electrons
are shared by the two species in question in the Born set up. Both Born and van der Waals
interactions are thus modeled in Eq.(3)’s EVAN DER WAALS term using the Lennard-Jones Potential
(Stobener, Klein, Reiser, Horsch, Kufer, & Hasse, 2014),

𝜎 6

𝜎 12

(6) 𝑢(𝑟) = 4𝜀 [− ( 𝑟 ) + ( 𝑟 ) ]

where 𝜀 and 𝜎 are constants related to the energy minimum and distance at minimum,
respectively.

3.2 FORCE FIELDS: MOLECULAR MECHANICS APPLIED

As stated in the previous section, the ultimate manifestation of the mathematical engine
that drives OpenContact©’s calculations is the atomic force field and associated parameters. It is
crucial to make the distinction however of what is meant by the term “force field” in chemistry
and computational biology as opposed to its more common usage in physics. In chemistry, a
force field refers to a system of potential energy functions like the kind that have been discussed
in the Equations 2 and 3. This stands in contrast to the definition of a force field in physics as
11

being the gradient of a scalar potential (Peters, 2007). Another important concept to be
cognizant of is that despite the fact that the equations in conjunction with their parameters are
called “force fields”, the quantities that the equations actually provide are potentials, not forces.
Strictly speaking, the force is defined mathematically as the negative of the first derivative of the
potential function with respect to distance. In addition to providing information on each element
present in the molecule, the parameters also include specific constants for the properties of these
atoms as they appear in different functional groups such as carbonyl and hydroxyl oxygens
(Krall, Brunn, Kankanala, & Peters, 2014).

The parameter sets used in proper force field analysis include data for van der Waals
radii, partial charges, atomic masses, equilibrium values for bond lengths and angles, dihedral
angles for bonded atoms and the effective “spring constants” for each bond potential (recall that
in molecular mechanics, bonds are well approximated by the physics of an actual expanding and
contracting spring) (Krall et al., 2014). An important point of emphasis is that despite the fact
that these values and constants are ultimately employed on a holistic perspective of the entire
protein under study, the values themselves are derived primarily from quantum mechanical
models on small and simple organic molecules (Cornell et al., 1995). As will be seen in the next
section, there are many force field models currently available for intra and inter molecular
interaction studies, and each model has its own set of parameters. These parameters are defined
by force field developers to be self-consistent within the parameters’ respective force field model
and should therefore never be used in conjunction with the potential equations from another
force field model, no matter how similar parts of the models may be.

12

3.3 AMBER 03: OPENCONTACT© DEFINED

The specific force field model used by OpenContact© is the AMBER 03 force
field. AMBER is an acronym standing for Assisted Model Building with Energy Refinement.
AMBER 03 follows the skeletons of Eqs. (2) and (3) and it has its own set of parameters for van
der Waals radii, bond lengths, etc…. There do exist other members of the AMBER family of
force fields that are popularly used but as mentioned earlier, each has its own exclusive
parameter sets that will only work with the force field model to which it belongs and it is this
proprietary attribute that defines the differences between individual members of the AMBER
family (Cornell et al., 1995).

Given that the parameter sets are the only attributes that differ between AMBER family
members, it should come as no surprise then that the foundational molecular mechanics potential
function for the AMBER family of force fields remains the same for each currently available
AMBER family member. The actual functional form of the AMBER equation is (Cornell et al.,
1995),

13

(7)

For the right hand side of this equation, the first term, which sums over bonds, models the
potential energy between covalently bonded atoms (Cornell et al., 1995). The classical spring
model is a good approximation for atoms participating in bonds, so long as the bound atom
distance (l) remains relatively close to the equilibrium bond length (l0). This model begins to
give poorer results, however, as the distance of binding is increased (Cornell et al., 1995). The
second term, which sums over the angles of electron orbitals (θ), models the potential energy of
electron orbitals involved in covalent bonding (Cornell et al., 1995). The third term, which sums
over torsion angles (ω), models bond rotation as influenced by bond order (i.e. double bonds vs.
single bonds) and neighboring charge clouds (i.e. vicinal bonds on the same atom and electron
lone pairs) (Cornell et al., 1995). It is possible for any given individual bond to have more than
one of these terms and in such cases, the total torsional energy potential would be expressed as a
Fourier series (Cornell et al., 1995). The fourth and last term (the double summation over i and
j) models the interactions arising from non-covalent force sources where rij is the distance
between the two interacting atoms in the system (Peters, 2007). Recall that these forces were
identified as being modeled by the Lennard-Jones potential for those non-covalent interactions
14

arising from time-dependent electron oscillation phenomena and Coulomb’s law for charged
atomic species.

4.0 MATERIALS AND METHODS: PRIMARY CONSIDERATIONS

At its foundation, this research project was purely computational and entailed feeding
raw protein structure data files into a suite of software applications to provide the desired output
data. This data then had to be compared (wild-type against mutant) to identify any differences
between wild-type and mutant strains. Ultimately, this required understanding the systems that
were going to be under study and establishing test subjects (the input data files) that had minimal
variability from one to the other within its respective system (a system being defined as a wildtype strain in conjunction with its mutant counterpart). Having an availability of both wild-type
and mutant data files in the first place was another criterion that had to be considered and
satisfied before a system could be approved for study.

Minimizing variability was a very important consideration in identifying which protein
systems would be analyzed. Each system had to, first and foremost, have its wild-type and
mutant strains come from the same organism. There were a plethora of promising systems that
either came from cattle, mice or even invertebrates such as insects and worms, but since the
focus of this research project was disease in humans, the ultimate candidates chosen had to come
from Homo sapiens, the species of man. The next criterion considered in minimizing variability
within each system was data file similarity. As shall be discussed shortly in greater detail, the
input data files essentially map the positions of each constituent atom of their respective proteins
in space. In many cases, there were multiple input structure data files for the same protein, from
15

the same species, but which covered/mapped entirely different regions of said protein. Naturally,
a system comprised of dissimilar locations for the wild-type and mutant strains would be of no
use to a systematic and rationalized study and so input structure data files had to be found that
had as much overlap as possible. An approved system would thus finally consist of both a wildtype and mutant strain (thus satisfying availability), and a wild-type and mutant set of structure
data files that had as much protein region overlap as possible (thus satisfying variability
minimization). Finally, it was decided that any system considered should not contain a cysteine
amino acid mutation, since these mutations can drastically alter the three-dimensional structure
of the protein, and the focus of this study was more on the subtle changes that could be incurred
from amino acid replacements that did not necessarily change protein structure. Although
residue mutations are the featured aberrancy in this study, it is important to keep in mind that
other factors associated with the environment of the system (i.e. pH, presence of solutes,
temperature etc…) can also have a profound effect on protein behavior. Thus this research
project only looked at just one aspect of how mutation states can affect protein-protein
interactions.

4.1 MATERIALS AND METHODS: PDB FILE ANATOMY

The input data files came from the Protein Databank or pdb website (www.rcsb.org) and
are consequently called “pdb files.” They are logged and registered in the databank according to
an accession number unique to each protein entry. These accession numbers are usually a
combination of alpha-numeric characters and they constitute the file name upon downloading.
The pdb files are inherently text files that can be viewed with any simple text editor. Notepad++
was specifically used to view and study the pdb files due to this piece of software’s designed
16

purpose of viewing machine instructions in interpreted code (i.e. high-level programming
languages). Although fundamentally pdb files bear the “.txt” file extension, they have an
additional appellative of “.pdb” following the normative “.txt” extension. It is the “.pdb” subextension that allowed these input data files to be read by the various computer programs used
which will be discussed in more detail in the coming sections. Here is a sample pdb file name as
would be downloaded from the Protein Databank: 4BXO.pdb.

What type of information specifically is encoded in these pdb files? The answer to this
question is a set of coordinates that detail where in space (a Cartesian-like x-y-z volume) each
and every constituent atom of the protein is located. This information is gathered from X-ray
crystallography studies, NMR assays or neutron diffraction studies. None of the test cases
reported here had their structures elucidated from the neutron diffraction assay however. From
the visualization software’s (DS Viewer Pro’s) perspective, this information is plotted and each
successive atom or point is connected to yield the overall tertiary structure of the protein. For
multi-chain proteins (which have each separate chain encoded in the same pdb file), each
individual chain’s atoms are also plotted and connected in the same space and the resulting
quaternary structure is then presented to the user. The section of the pdb file that encodes atom
positions obeys the skeleton as shown in Fig. A1 (see appendix). Below is the definition for each
column entry:



Column1: field for the actual species to be plotted, which for this example is an atom.



Column 2: field for the sequential number of the corresponding atom (the value of this
field will naturally increase by one as one moves down Column 2).
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Column 3: field for the specific atom name with respect to the amino acid residue to
which the atom belongs (i.e. the alpha carbon, amino nitrogen, carbonyl oxygen, etc…).



Column 4: field for the standard three-letter amino acid code for the residue.



Column 5: field for the protein chain that particular residue’s atom belongs to.



Columns 7, 8 & 9: fields for the x-y-z coordinates respectively of each atom.



Column 10: field for the occupancy value of the atom.



Column 11: field for the thermal factor of the atom.



Column 12: field for the explicit chemical element of the atom (i.e. carbon, nitrogen
etc…).

This example was taken from the transthyretin protein (accession number: 3D7P), one of the test
cases. Following the plotting of the above data, DS Viewer Pro then allows rotation of the image
to see the three dimensional structure in depth and from different angles. There are a host of
other features likewise available in DS Viewer Pro that allow for selective hi-lighting of amino
acid residues, labeling the distinct chains (if there are more than one) and zooming in to regions
of interest on the protein, just to name a few. It is important to keep in mind however that
despite the fact that the pdb file encodes raw atom positions, the output labelling is primarily
from the perspective of the amino acid residue.

In addition to atom positions, the typical pdb file will also include information on the
type of experiment that yielded the protein’s structural results (i.e. X-ray diffraction, NMR,
neutron scattering), the resolution of the imaging, the position of mutations in the primary
structure of each protein chain (if the pdb file is of a mutant strain), the name of the protein, any
missing atoms or residues, and the names of the authors who elucidated the structure.
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Depending on the depth of study from the researchers who compiled the pdb file, there may even
be a section detailing additional suggested pdb accession numbers for related protein structures.
Figures A1 and A2 show snapshots of the two important sections of a typical pdb file (taken
again from transthyretin-3D7P),

4.2 MATERIALS AND METHODS: OVERALL EQUIPMENT

Due to the computational nature of this research project, the principal pieces of
equipment consisted of two main classes: computer hardware and software. Hardware-wise, a
Dell® Inspiron 15 laptop computer with an Intel® Inside™ CORE™ i3 processor with 4
gigabytes of RAM was used. Data was saved on said machine as well as on various disk drives
for backup in case of primary storage failure. Software-wise, OpenContact© was used to
process raw input data (the pdb structure files from the Protein Databank) and consequently
provided quantitative output calculation results for criteria such as inter-atomic distances and
Lennard-Jones Potentials which was then processed and organized using Micrsoft Excel
spreadsheeting. OpenContact© also provided qualitative contact mapping plots for the same
inter-atomic criteria mentioned above as well as molecular visualization files of the output data
for qualitative analysis as well. Consequently, the other indispensable piece of software used
was DS Viewer Pro®, a molecular visualization program that would read the same input files
that were fed to OpenContact©, but instead provided output in the form of a 3 dimensional
image of the protein encoded by the input data. As with many available molecular visualization
software, DS Viewer Pro® permits for the rotation of the three dimensional images so as to allow
viewing the molecules from different angles.
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4.3 MATERIALS AND METHODS: DS VIEWER PRO®-THE FIRST STEP

Once a protein system was selected, the first step in analysis was looking at the entire
structure of both wild-type and mutant strains. Such a qualitative approach served to primarily
gain an appreciation and knowledge of the location of the general residues potentially involved
in intra-protein binding. The software that was used to provide these molecular visualizations
was DS Viewer Pro by Dassault Systems BioVia. Despite the fact that there were a number of
other molecular visualization programs available for potential use, DS Viewer Pro was ultimately
selected due to the publication quality of its output data files. The actual artistic representation
style of the protein structure deployed by DS Viewer Pro was in the hands of the user. The most
common method seen thus far by the author in text-books and scientific articles is the flat ribbon
representation. Below is a sample of this representation of molecular structure, again, for
transthyretin, accession number 3D7P,

Fig. 1: Flat ribbon representation of transthyretin (wild-type).

As alluded to earlier, DS Viewer Pro Due provides many features to the user in displaying
protein structure from pdb files. One such feature that proved to be most curious but useful in
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studying the detailed position of residues and their constituent atoms was the option of
overlaying a wire-frame representation of each and every atom present in the pdb file over the
general flat ribbon structure. The same transthyretin structure with its atoms overlaid the ribbon
representation is shown in Figure A3. Other representation schema available included wire,
stick, line ribbon and schematic, to name a few. The same transthyretin protein is shown in Figs.
A4-A7 in these different representations. It should be noted however that in some specific
instances to be seen later, the schematic representation (Fig. A7) proved to be more appropriate.

One of the more powerful and informative features of DS Viewer Pro was the ability to
see and selectively hi-light residues in a protein structure. The following image showcases this
ability for the same wild-type transthyretin model with the specific amino acid that was to be
mutated in the mutant pdb file, here hi-lighted yellow,

Fig. 2: Transthyretin with valine at the 30th position hi-lighted

Next is the same image, but with the residue names showing. Again, the same amino acid is hilighted in yellow.
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Fig. 3: Transthyretin with all residues displayed; valine at 30th position hi-lighted yellow

It is important to note however that select residues such as valine at the 30th position cannot be
solely displayed all the while ignoring (i.e. not displaying) the other residues in the protein. If
such images are desired, a manual labeling via the use of superimposed text boxes over the bare
protein structure would have to be employed.

4.4 MATERIALS AND METHODS: OPENCONTACT©- THE NEXT STEP

Following the preliminary structure viewing of the overall protein system, the next step
was to execute OpenContact© on both the wild-type and mutant strains for the given system
under study. OpenContact© is a simple, yet powerful static contact mapping algorithm that has
been developed as a first step at identifying binding “hot-spots” in protein-protein interactions
from interaction partner structure files (Krall et al., 2014). The algorithm is fast and provides
results on a Windows© based laptop or PC within approximately two minutes even for large
protein systems. It has been demonstrated that OpenContact© is capable of identifying key or
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critical inter-atomic hot-spots in PPI’s previously obtained via more sophisticated methods such
as MD or docking methods (Krall et al., 2014). Again, such results furnished by this algorithm
were provided very quickly within a two minute time window and it additionally had the benefit
of not requiring the user to have any sophisticated knowledge associated with carrying out large
scale MD or docking methods. Thus, a large number of systems can be quickly mapped as an
initial step to potentially ascertain the roles of PPI’s in protein behavior. What now follows is a
general overview of the input protocol and considerations for inputting the pdb data file into
OpenContact©. As has been discussed thus far, OpenContact© calculates inter-atomic distances,
and force potentials by reading in the pdb files containing atomic position data. The exact nature
by which this is done is by first specifying the two chains of the protein that one wishes to study
(only two chains can be analyzed at any given algorithm execution however). Below is a
snapshot of the graphical user interface (GUI) of OpenContact© by which this first step is taken,
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Fig. 3: OpenContact© GUI

Several details worth noting from this image are the two populated browse input fields located in
the section marked “Protein Input.” It is in this field that the user would specify (most
conveniently by using the browse buttons with folder icons) the directory pathway of the input
pdb files. Again, there are two pathway fields to allow the study of the interactions of two chains
(Krall et al., 2014). Since the backbone of these computational calculations is the actual
structure encoded by the pdb file, the two pathways will naturally direct to the exact same file.
This will not always be the case however, especially with single chain protein systems as will be
seen shortly. The next item to consider in Fig. 3, still in the “Protein Input” section, is the “Chain
ID” input text box located immediately underneath each directory pathway. As this field’s name
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suggests, the appropriate input to this field is the specific chain one wishes to include in the
computation study (Krall et al., 2014). It is absolutely important that the chains specified are
actually logged in the pdb file however, as the program will be unable to proceed if it is unable to
find what is provided. Once directory pathways and chain ID’s have been specified, the “Add”
button must then be clicked to formally feed these results into OpenContact©. Following pdb
file and chain specifications, the next two items of consideration are now in the section titled
“Options.” The pathway field marked “Output Destination” would point to a directory location
where the user would like to store the output files generated by OpenContact©. The text box
marked “Filename Convention” would direct OpenContact© with the paradigm for naming the
output files (Krall et al., 2014). As can be seen, file-naming by date of creation, protein names
and batch id are some options left to the user to choose from. Finally, the radio button marked
“Create new folder for each mapping” does as its name suggests: if the same overall destination
folder is maintained for separate runs, each run will be stored in a newly created folder
automatically generated by OpenContact© (Krall et al., 2014). Once each of the aforementioned
fields have been populated and the “Add” button depressed, the last and final step of the data
input protocol is to depress the bottom-most button marked “Run.” A green bar will then
qualitatively indicate the stage of the program’s data processing (i.e. the green bar will grow as
the process approaches completion) and once the procedure is complete, the output files will be
stored in the directory specified.

The precise nature of the output data files is essentially divided along two criteria: fine
parsing and coarse parsing, of the calculated potentials and distances (Krall et al., 2014). For the
coarse parsing criterion, atom-atom separation distances greater than 10.5 angstroms are
excluded from the final data file (Krall et al., 2014). In the fine parsing of the interactions, an
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additional restriction on the atom-atom interaction potentials are specified. For all the results in
the coming sections, the upper limits to restrict Coulombic and Lennard-Jones interactions are
(respectively) (Krall et al., 2014),

∗
(8) 𝑈𝐶𝑜𝑢𝑙
≤ −0.3

or,

∗
(9) 𝑈𝐿𝐽
≤ −0.1

where,

(10) 𝑈 ∗ =

𝑈
𝑘𝑇

for both interaction criteria. In Equation 10, k is Boltzmann’s constant and T is temperature
taken as 310.15 K for all results that follow (Krall et al., 2014). Consequently, the values
reported by OpenContact are dimensionless where potentials have been scaled by kT and
distance has been scaled by 1 nano-meter. These potential energy cut-offs ensure that only the
strongest attractive interaction potentials for any given type are included in the fine parsing
results which are provided to the user in a highly manageable and user-friendly format in both
“.pdb” and “.txt” file types (the “.txt” file is purely a text file that allows its data content to be
properly imported into Microsoft Excel for spreadsheeting) (Krall et al., 2014). The data can
now be analyzed, plotted and generally manipulated according to the user’s needs as shall be
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seen in the coming cases. At its most basic, the fine parsing data thus provides which atom-atom
interaction pairs exhibit the strongest interactions, whereas the coarse parsing data provides
which atom-atom interaction pairs contribute most to the structure involved in the inter-chain
bound region (Krall et al., 2014). For the studies that follow in this research project, the coarse
parsing data provided the greatest insight into the structural changes exhibited by mutant strains
compared to their wild-type counterparts.

Following the above data input protocol, the user is now able to do one of two things:
view and manipulate the output data files, or create a contact mapping plot of the two chains
based on Coulombic, Lennard-Jones or distance criteria. This plot inherently uses the output
data from the fine parsing files already generated but it presents that data in a pictorial format
that provides a very nice overview of the atom-atom interactions between the two chains
specified. Below is a snapshot of such a plot, again, for wild-type transthyretin, accession
number 3D7P,
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Fig. 4: Contact map plot for distances between atoms in chains
A and B for transthyretin.

As can be seen in Fig. 4, the corresponding x and y axes display specific atoms involved in the
interactions between chains A and B for transthyretin. The y axis (marked “Protein A”) presents
the participant atoms from the A chain in ascending order (from the bottom of the axis to the top
of the axis) and the x axis (marked “Protein B”) presents the corresponding atomic partners from
the B chain that interact with the A chain atoms. The atoms in the x axis are not in any particular
order however. It is important to also note that despite the fact that a certain number of atoms
may be explicitly presented in the above plot, the actual fine parsing analysis may detect
hundreds more. Again, these plots are more qualitative in nature, but they can provide a very
good overall picture of how the system’s wild-type or mutant strains interactions behave. The
informative nature of the plot ultimately comes from the bright colors in the actual plot area:
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brighter colors at certain ordinate and abscissa intersections indicate stronger interactions, or, as
is the case for Fig. 4, closer separation distances. The color-coded legend to the right of the plot
in the figure provides a neighborhood for the corresponding values. Although powerful, for the
present application, these contact plots were not used, as structure image files were the central
starting point for analysis of the input files and results.

As briefly mentioned in the preceding paragraphs, OpenContact’s cut-off limits were
determined to be efficient for the research project undertaken by Peters et al. which was finding
regions of certain proteins involved in disease that were amenable to synthetic peptide (biomimetic peptide) targeting for therapeutic use. A total of six unrelated protein systems were
analyzed in the Krall et al. study and included gp41 (a glycoprotein belonging to HIV that is
necessary for host cell entry), the EpherinB4-EpherinB2 system (a cell-cell signaling
angiogenesis stimulation mechanism), Myc-Max (a transcription factor hetero-dimer complex
involved in cell proliferation), and EGFR-EGF (a cell growth factor system). According to the
results of the study, the OpenContact© algorithm “efficiently predicted proposed peptide
biomimetics, or close variations thereof” when compared against peptide mimetics that had been
proposed and/or developed for these systems to some degree of success by purely experimental
methods (Krall et al., 2014).

4.5 MATERIALS AND METHODS: OUTPUT FILE ANATOMY

Since the primary focus of this study was interaction changes from the wild-type to the
mutant version of the protein, the discussion that follows comes from the results of the fine
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parsing output data. Coarse parsing data obeys the same format however. These results
generated by OpenContact© were consequently interpreted in the following manner. First the
entire protein system was analyzed holistically by summing the two potential criteria (Coulombic
and Lennard-Jones) for both the wild-type and mutant strains. This permitted seeing how the
totality of interactions changed on a big picture scale. The interatomic distances by contrast
were averaged to get a sense of how average distances changed. Then, common interaction
partners amongst the two strains were identified and only the common interaction potentials and
distances were summed and averaged respectively as described for the holistic scenario. From
the fine parsing data (imported into Microsoft Excel), common interaction partners were hilighted in green to differentiate them from interactions unique to each strain. Two corresponding
common entries for transthyretin’s fine parsing analysis are shown in Figs. 5 and 6.

Fig. 5: Fine parsing analysis data for transthyretin. The wild type results are in the left-hand
table, mutant results are at the right. Two sample common interaction entries are bordered in red.
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Fig. 6: Fine parsing data hi-lighting actual data content. The columns headed by “RRS” (blue),
“UCOUL” (magenta) and “UL” (orange) contain the data for distance, Coulombic potentials and
Lennard-Jones potentials respectively.

What is ultimately meant by common interaction partners refers solely to the entries
headed by “RES A,” “RES NUM,” “ATOM A,” and “RES B,” “RES NUM,” “ATOM B” in the
column titles in Figs. 5 and 6. Should the individual entries in these columns within one table
identically coincide with entries in the same columns in the other table, then those elements
within the two tables were considered common interaction pairs. As mentioned earlier, some
structural elucidation assays may result in certain atoms or residues not being detected and thus
not reconciled in the pdb structure file. This would result in those residues or atoms being
omitted from the orderly enumeration dictated by the “ATM NUM” column. It is for this reason
that this column is not used in determining common interaction partners: individual atom
numbering may change from experiment to experiment, but residue numbering never does.

4.6 MATERIALS AND METHODS: DATA RECONCILIATION
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Since the ultimate goal of this research project was to compare the interactions between
wild-type and mutant strains of the same protein, the overall approach was to sum the three
interaction criteria together (or average them for the distance criterion) and compare the results.
In turn, these interaction totals were carried out over three analysis considerations: an overall
comparison, a common atom comparison and a non-common comparison. The overall
comparison was simply a total of each of the interaction criteria (Lennard-Jones potential,
Coulombic potential and distance) and the total of each criterion was compared between the
wild-type and mutant strains. The common atom comparison consisted of identifying the atomatom interactions that were found in both the wild-type and mutant strains (green text in Figures
5 and 6), summing these values for each strain and then comparing the sums. The non-common
comparison in turn consisted of summing all atom-atom interactions that were unique to each
strain, and likewise comparing these sums.

Once these sums were executed, the comparison of the data had to have some threshold
for what would be considered significant and what could be disregarded as deviations arising
from experimental artifacts (these artifacts coming from the conditions employed in the
crystallography experiments). Normal artifacts due to experimental conditions that can vary on
the atomic scale when crystallographic procedures are being executed is typically around 5-7%.
Thus, the threshold for consideration was decided to be a minimum of approximately 10%
difference between comparable criteria of both wild-type and mutant strains.

5.0 SYSTEMS ANALYZED: TRANSTHYRETIN
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The first system considered in the analysis was the protein transthyretin. Transthyretin in
its physiological state is a tetramer made up of two sub-units where each subunit is in turn a
homo-dimer. The molecular weight of each monomer is 15.89 kDa for a total molecular weight
of 63.56 kDa for the biologically active tetramer (“TTR(human),” 2014). For this study, the
homo-dimer was selected according to the availability, non-cysteine residue mutation and
minimization of variability criteria discussed earlier. Below is an image for the wild-type and
mutant strains studied, accession numbers 3D7P and 3DJT respectively,

Fig. 7: Dimer of transthyretin wild-type (7a) and mutant (7b). Accession
numbers 3D7P and 3DJT respectively.

Figures A10 and A11 show the biologically active transthyretin tetramer as well as the above
dimer from a different angle.

Transthyretin is a carrier protein of two species: the thyroid hormone thyroxin and the
lipocalin retinol binding protein which is itself bound to retinol (a form of vitamin A). It is from
the transport of these two molecules that transthyretin derives its name: transports thyroxin and
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retinol (Palinathan, Mohamedmohaideen, Snee, Kelly, & Sacchettini, 2008). The liver secretes
transthyretin into the blood and the choroid plexus transports it into the cerebrospinal fluid.
Thyroxin is a tyrosine-based hormone that acts on almost every cell in the body and ultimately
plays a role in regulating the basal metabolic rate, long bone growth, neural maturation and even
protein synthesis (Palinathan et al., 2008). It is produced in the thyroid gland and requires iodine
for its synthesis (Palinathan et al., 2008). Incidentally, an iodine deficiency results in underproduction of this hormone which in turn results in enlarged thyroid glands, the condition of
which is known as simple goiters. One of the biological significances of transthyretin therefore
lies in its ability to distribute thyroxin throughout the body so that the aforementioned biological
processes of metabolism and cellular growth rate may not be impaired (Palinathan et al., 2008).
The second chemical species transported by transthyretin, retinol, is responsible for a variety of
functions such as maintaining vision, skin health, teeth re-mineralization, and bone growth
(Palinathan et al., 2008). The exact avenue by which retinol affects these diverse systems
depends on what form retinol (an alcohol) is converted to. As an aldehyde (retinal) it affects
vision, as a carboxylic acid (retinoic acid) it affects skin health, teeth re-mineralization and bone
growth (Palinathan et al., 2008).

Of important consequence to this study is the location of the active site for this and all the
proteins that follow. In total, transthyretin carries one thyroxin molecule, and two retinol
molecules via the retinol binding protein. For transthyretin, the studies by Monaco showed the
active sites for the biologically active tetramer to be located on the outside of the complete
tetrameric complex for the retinol binding protein, and within the cavity of the tetramer for
thyroxin. The following image shows these active sites,
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Fig. 8: Retinol binding protein binding sites (red) and the thyroxin active site (green). The
retinol binding proteins are on the right and left of the transthyretin complex with retinol bound
and shown as a space filling model. The thyroxin binding site is shown empty.

When this protein is defective due to specific residue mutations, a serious condition
known as Familial Amyloid Polyneuropathy (FAP) can occur (also known commonly as Corino
de Andrade’s Disease, named after the Portuguese neurologist who first described it). FAP is an
autosomal dominant neurodegenerative disease characterized by pain, parathesia (pins-andneedles sensations), muscular weakness and autonomic dysfunction (Cendron, Trovato, Seno, &
et al., 2009). As the scientific name of this disease suggests, FAP is an amyloidogenic disorder,
(like Alzheimer’s and Parkinson’s diseases) wherein amyloid plaque builds up in the brain and
results in a general loss of motor function (Cendron et al., 2009). In FAP, amyloid plaques of the
mutated protein accumulate in the peripheral nervous system causing a progressive sensory and
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motor polyneuropathy (Cendron et al., 2009). Polyneuropathies are damage to multiple nerves in
roughly the same area on both sides of the body that lead to weakness, numbness, pins-andneedles sensations (parathesia) and burning pain. The heart and kidneys are affected in the
terminal state of this disease (Ando & Jono, 2008). The mutant strain of the transthyretin protein
analyzed for this study was a missense mutation resulting in the replacement of Valine by
Methionine at the 30th position (V30M) which was not located near any of the active sites (see
Figure A10). This is the mutation that is most commonly found in FAP cases (accession number
3DJT) (Cendron et al., 2009). Wild type transthyretin has a half-life of roughly two days in the
body (Ando & Jono, 2008). However no information could be gathered for the mutant version of
the protein which would have provided useful insight relating the persistent amyloid deposits to
the time they reside in the body. OpenContac© was thus performed to analyze the inter-protein
chain interactions for this system using Chain A of 3DJT mapped against Chain B of 3DJT. Only
these inter-protein interactions were analyzed, not the binding of the ligands of thyroxin or the
retinol binding protein.

The so-called “Fine Parsing” results for the transthyretin mapping indicated that the
mutant strain exhibited greater interaction from the Lennard-Jones criterion than the wild-type
(Table 1). From the total Coulombic interaction and the average distance criteria however, the
differences between the two strains were not significant. Note that “UL TOT” and “UCOUL
TOT” are the sum of all Lennard-Jones and Coulombic atom pair interactions respectively from
the Fine Parsing output.
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Table 1: Fine Parsing Results for Transthyretin
WT

MUT

%

UL TOT:

-5.41E+01

-6.36E+01

15%

UCOUL TOT:

-2.38E+02

-2.46E+02

4%

6.07E-01

5.82E-01

4%

DISTANCE (AVG):

Statistically significant values are hi-lighted: red for potentials and blue for distances. Thus
overall, the two strains for this system seem to show little structural variance between them as far
as their fine parsing inter-chain interactions were concerned. Visually, this can be seen by
comparing the fine parsing images (chains have been hi-lighted and labeled),

Fig. 9: transthyretin wild-type (9a) and mutant (9b) fine parsing
Wild-type residue range: 33-122 (A chain), 41-122 (B chain)
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Mutant residue range: 39-122 (A chain), 39-122 (B chain)

By considering the shift in Lennard-Jones interactions when going from the wild-type strain to
the mutant strain, one can see that the mutation permits a novel situation wherein the noncharged, non-polar residues are now interacting stronger in the mutant strain. Non-charged and
non-polar residues are usually associated with the interior region, or endo-domains, of a protein
and are hydrophobic in nature so the conclusion from the overall analysis of the protein is that its
interior has stronger hydrophobic interactions in the mutated form. The schematic representation
was used for fine parsing visualization, as it permits visualization of the most basic alpha carbon
backbone which is very often lost with ribbon representation. This paradigm will be used
throughout this study.

From a structural perspective, the coarse parsing also seemed to show overall retention of
structure (Fig. 10).
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Fig. 10: Transthyretin wild-type (10a) and mutant (10b)

Wild-type residue range: 12-124 (A chain), 11-124 (B chain)
Mutant residue range: 11-124 (A chain), 11-123 (B chain)

In order to further quantify changes in protein-protein interaction (PPI) behavior,
common and un-common atom-atom interactions between the two strains were identified from
OpenContact© Fine Parsing spreadsheets. The common interactions were atom-atom pairs
found in both wild-type and mutant strains whereas the un-common interactions represent those
atom-atom pairs that were unique to each strain. For this analysis, virtually every residue present
in the whole fine parsing output had a constituent atom participate in common interactions (i.e.
almost all residues are common residues). The results for the common atom-atom interactions
are shown in the Table 2.
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Table 2: Common Results for Transthyretin
WT

MUT

%

UL TOT:

-3.68E+01

-3.59E+01

2%

UCOUL TOT:

-2.12E+02

-2.24E+02

5%

5.94E-01

6.03E-01

1%

DISTANCE (AVG):
COMMON ATOMATOM PAIRS:

543

For these interaction pairs, one can see that there was little deviation between the wild-type and
mutant strains. Intuitively, this makes sense as the atom-atom interaction pairs considered are
identical in their participants between the wild-type and mutant with very little overall structural
changes. The analysis of the un-common interactions thus considered the remaining atom-atom
pairs that were unique to each individual strain. The results for this analysis are shown in Table
3.

Table 3: Un-common Results for Transthyretin

UL TOT:
UCOUL TOT:
DISTANCE (AVG):
UN-COMMON ATOMATOM PAIRS:

WT

MUT

%

-1.72E+01
-2.64E+01
6.35E-01

-2.77E+01
-2.13E+01
5.46E-01

38%
19%
14%

258

307

By identifying only the un-common interaction partners, a clear shift was seen going from
Coulombic to Lennard-Jones when going from the wild-type to the mutant. Additionally, the
average inter-atomic distance decreased slightly as visually evident by overlaying Fig. 9a over
Fig. 9b (not shown). It is interesting to note that despite these findings, the biology of the disease
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state still permits transport of the two ligands (thyroxin and the retinol binding protein) (Cendron
et al., 2009). This is consistent with the lack of overall structural changes. How the subtle
change or shift in PPIs affects plaque formation is not known, but these PPI changes have been
clearly detected here.

5.1 SYSTEMS ANALYZED: SOD1

The next system that was analyzed was the enzyme SOD1. The biologically active form
of this enzyme is a homo-dimer with each monomer having a molecular weight of 15.94 kDa for
a total molecular weight of 31.88 kDa for the whole protein (“SOD1 (human),” 2014). Below is
an image of the wild type and mutant strains that were used for this study (accession numbers
4FF9 and 3GZQ respectively),

Fig. 11: SOD1 dimer enzyme wild-type (11a) and mutant (11b). Accession numbers 4FF9 and
3GZQ respectively
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Superoxide dismutase 1, or SOD1, is an enzyme that is responsible for destroying
superoxide radicals in the human body (Auclaire, Brodkin, D’Aquino, Petsko, Ringe & Agar,
2013). It belongs to a general family of enzymes known as superoxide dismutases that catalyze
the dismutation of superoxide (O2-, a free radical) into diatomic oxygen and hydrogen peroxide
thus making the enzyme an extremely important anti-oxidant (Auclaire et al., 2013). The
presence of superoxide in biological systems, specifically in humans, comes from the byproducts of mitochondrial respiration as well as from the immune system which specifically
manufactures superoxide for use in oxygen-dependent killing mechanisms of foreign invading
pathogens (Auclaire et al., 2013). Being a free radical, superoxide is extremely toxic due to its
high reactivity and can readily react with (and therefore alter) DNA. The neutralization of
superoxide is accomplished by the presence of metal ions in an accessible region of the protein
(its active site, though more on this later) that consequently makes SOD1 and the other SOD
proteins metalloproteins (Auclaire et al., 2013). The three families are distinguished from one
another according to the specific metal/metals present in the active site, which in turn dictates the
location of activity (i.e. intracellular or extracellular) or the specific types of organisms serviced
by the dismutase (Galaleldeen & Strange, 2009). The subject of study for this project was the
human superoxide dismutase known as SOD1 which is found in the cytoplasm of cells and
contains copper and zinc as its active site metal ions, both of which are in the +2 oxidation state
(Ramirez, Mejiba Gomez, & Mason, 2005). The other two classes of SOD, SOD2 (which uses
iron or manganese) and SOD3 (which uses nickel) are also found in humans in the mitochondria
and extracellular fluids respectively (Selverstone Valentine, Doucette, & Zittin Potter, 2005).
Prokaryotes will either use SOD2 or SOD3 for their superoxide neutralization protocols
(Selverstone Valentine et al., 2005).
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Each individual monomer in SOD1 is built upon a β barrel motif with one copper and one
zinc binding site. Two large loops called the electrostatic and zinc loops encase the metalbinding region which serves as the active site (although the heart of enzymatic activity revolves
around the copper ion). Thus the whole biologically active SOD1 enzyme has a total of two
active sites, one on each monomer. Below is the entire enzyme with the metal ions in the active
site hi-lighted as reported by Selverstone Valentine et al.,

Fig. 12: SOD1 enzyme (wild-type) with loop regions and active site

The overall enzymatic activity of SOD1 is described in the following chemical reaction equation
as given by Selverstone Valentine et al.,

(11) 2𝑂2− + 2𝐻 + → 𝑂2 + 𝐻2 𝑂2
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where two hydronium ions (technically shown here as free protons) from the aqueous in vivo
environment provide the necessary hydrogens to evolve hydrogen peroxide. Considering the
detailed chronological mechanism by which the cupric ion participates involves a two-step
reaction process. The first step is shown next,

(12) 𝑂2− + 𝐶𝑢2+ 𝑍𝑛𝑆𝑂𝐷 → 𝑂2 + 𝐶𝑢+ 𝑍𝑛𝑆𝑂𝐷

Here, one molecule of superoxide first reduces the cupric ion to the cuprous oxidation state (+1)
to form diatomic oxygen. The second reaction that yields the final hydrogen peroxide product is
shown next,

(13) 𝑂2− + 2𝐻 + + 𝐶𝑢+ 𝑍𝑛𝑆𝑂𝐷 → 𝐻2 𝑂2 + 𝐶𝑢2+ 𝑍𝑛𝑆𝑂𝐷

Thus the copper ion is returned to the cupric oxidation state thereby regenerating the enzyme for
further activity.

Should a mutation occur, a disease known as amyotrophic lateral sclerosis or ALS
(known as Lou Gehrig’s disease in the United States) can develop. ALS is a neurodegenerative
disease characterized by rapidly progressing weakness due to muscle atrophy, muscle spasticity,
difficulty speaking, swallowing and breathing (Galaleldeen & Strange, 2009). Although the
disease can be inherited, this mode of acquisition only applies to about 5%-10% of cases (thus
termed familial ALS) with the majority of incidents occurring spontaneously (Galaleldeen &
Strange, 2009). These symptoms are brought about by the gradual degeneration of the upper and
lower motor neurons and although all voluntary movement is ultimately lost, bladder and bowel
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functions as well as the muscles responsible for eye movement are typically spared until the final
stages of the disease (Galaleldeen & Strange, 2009). Interestingly, cognitive function is
generally spared for most ALS patients, although some 5% of sufferers may develop
frontotemporal dementia (Galaleldeen & Strange). Survival time with this disease is around 39
months from the onset of symptoms and death is ultimately caused by respiratory failure. A
well-known case of ALS is that of cosmologist Stephen Hawking who first started displaying
symptoms during his years at Cambridge University as a doctoral student. He has since lived
with this disease for more than 50 years, however his case is exceptional. The exact mechanism
by which patients experience a gradual loss of neuronal function is as of yet still unknown, but
aggregates of large fibrils of proteinaceous inclusions rich in mutant SOD1 are characteristic of
tissue samples from ALS patients (Selverstone Valentine et al., 2005). As has been proposed for
ALS and other neurodegenerative diseases, the fibrils themselves may not be the toxic species as
they are formed relatively late in the disease, but instead may be a final accumulation of the
insoluble protein form as the body becomes incapable of handling such a large buildup. This
scenario might therefore lead one to believe that the half-life of the mutant strain is longer than
that of the wild-type since fibrils of mutated protein are found in the aggregates. Interestingly
enough, this is not the case. According to Selverstone Valentine et al., wild-type human SOD1
has a half-life of 30 hours. This is dramatically different from the mutant’s half-life (specifically
the mutant that was studied) which is 7.5 hours. The mutant strain utilized in this study was the
A4V mutation, accession number 3GZQ.

The overall fine parsing analysis for SOD1 yielded results that were by and far too close
between the wild-type and mutant strains to be considered favoring either. Below is the table
summarizing these results,
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Table 4: Fine Parsing Results for SOD1
WT

MUT

%

UL TOT:

-3.99E+01

-4.07E+01

2%

UCOUL TOT:

-2.34E+02

-2.11E+02

10%

6.55E-01

6.43E-01

2%

DISTANCE (AVG):

Thus the data implies a striking similarity in binding interactions between both wild-type and
mutant amongst all of the atom-atom interactions responsible for keeping the two sub-units
together. The pdb molecular representation for this fine parsing data is shown below,

Fig. 13: SOD1 wild-type (13a) and mutant (13b) fine parsing
Wild-type residue range: 3-153 (A chain), 1-153 (B chain)
Mutant residue range: 1-153 (A chain), 3-153 (B chain)
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Positions that underwent mutations are circled in Figures 15 and 16 as this will be the paradigm
for all the images that are to follow, should there be a mutation present in the fine or coarse
parsing output images. One item of note to point out is that the original pdb input data file for
the wild-type and mutant had the A and B chain nomenclature reversed. This was of no
consequence however for OpenContact© as the results yielded are not dependent on chain name.

An interesting aspect of this case was that the residue position (the 4th position) that was
mutated also participated in inter-chain binding as seen in Figures 15 and 16 (also recall Figure
A11 which shows this residue position near the inter-chain region). The specific differences
between the interactions for the mutated position alone is shown in the table below,

Table 5: SOD1 Mutant Position Comparison (4)

UL TOT:
UCOUL TOT:
DISTANCE (AVG):

WT

MUT

%

-7.53E-02
-6.12E+00
7.62E-01

-5.21E-02
-3.56E+00
7.79E-01

30%
42%
2.00%

Although the mutated residue position was present in the fine parsing studies for both strains, it
is crucial to point out that not all of the same atom-atom binding pairs participated in binding.
As it turned out, the wild-type had fourteen of its constituent binding pairs participate whereas
the mutant only had ten. Nonetheless, the wild-type’s binding pairs exhibited considerably
stronger interactions as seen in Table 5. Interestingly enough, despite superior binding from the
wild-type, the average distance for both strains were almost identical.
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With respect to the structural changes, the mutant strain exhibited some considerable
change from the wild-type and even showed the development of secondary structure in the form
of an anti-parallel beta sheet. These results are shown below,

Fig. 14: SOD1 wild type (14a) and mutant (14b) coarse parsing
Wild-type: 1-153 (A chain), 1-153 (B chain)
Mutant: 1-153 (A chain), 2-153 (B chain)

As can be seen, there is a significant change in structure in the mutant, particularly a noticeable
introduction of beta sheet formation in the mutant as well as a re-orientation of sorts of the
mirror image symmetry of the two mutant chains. Where the wild-type has inverted mirror
image symmetry (with each mutant position on opposite ends), the mutant is a very good mirror
image of the two constituent chains. More striking is how, as a result of this, the mutated
position is now very much in symmetry in the mutant strain. As in the fine parsing results, the
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mutated residue shows up in both strains and is noticeably closer to the interior of the binding
region in the mutant compared to the wild-type.

When considering the atom-atom interactions common to both the wild-type and mutant
strains, a similar trend of virtually equal interactions across all three criteria is observed. The
following table summarizes these results,

Table 6: Common Results for SOD1
WT

MUT

%

UL TOT:

-3.29E+01

-3.26E+01

1%

UCOUL TOT:

-2.00E+02

-1.99E+02

1%

6.44E-01

6.42E-01

1%

DISTANCE (AVG):
COMMON
ATOM-ATOM
PAIRS:

606

As would be expected, there was practically no change of interaction type when going from the
wild-type to the mutant strain. As was observed for transthyretin, these common interactions
pertained to virtually every residue from the fine parsing output.

Upon examination of the un-common interactions however, one can see that there begin
to be signs of bias in favor of the wild-type strain or the mutant strain depending on the
interaction criterion considered. These results are summarized below,
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Table 7: Un-common Results for SOD1

UL TOT:
UCOUL TOT:
DISTANCE (AVG):
UN-COMMON
ATOM-ATOM PAIRS

WT

MUT

%

-6.91E+00
-3.42E+01
7.00E-01

-8.10E+00
-1.19E+01
6.47E-01

15%
65%
8%

148

108

The results indicate that the mutant strain contains greater Lennard-Jones interactions, again
strongly associated with non-polar residues, and that the wild-type presents an even greater
proportion of electrostatic activity associated with polar residues.

5.2 SYSTEMS ANALYZED: P53

The next system analyzed was p53, a protein highly involved in DNA repair and
programmed cell death (apoptosis) that is strongly linked with incidences of cancer. The
biologically active form of P53 protein is that of a tetramer complex composed of four identical
subunit chains. Each chain has a mass of 43.7 kDa for a total mass of 174.8 kDa (“p53
(human),” 2014). Below is an image of wild-type p53 as it would be found executing its DNA
reparative function as reported by Malecka, Ho, & Marmorstein, 2009,
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Fig. 15: p53 tetramer complexed to DNA

Although the above image is of the whole protein, it must be noted that crystallizing the entire
protein is difficult due to the inherent flexibility of p53 that is part of its biological activity and
function (more on this later) (Mora & Carbajo, 2008). Thus the structure pdb file available for
study was only of the tetramer’s binding domains. The wild type strain employed for this study
was of the accession number 2J0Z (Mora & Carbajo, 2008).

p53 is an important protein involved in repairing DNA damage and is thus extremely
important in cancer cell systems (Goodsell, 2014). Over 70% of all cancers exhibit some form of
p53 mutations regardless of whether or not the mutations are acquired post-nattily or inherited
(Gao et al., 2013). In general, mutations that lead to cancer abide by either one of two
mechanisms: a mutation that results in uncontrolled growth/multiplication of cells or mutations
that block the normal defenses responsible for protecting against unnatural growth (Goodsell,
2014). Consequently, cancerous cells will exhibit mutations that affect either one (or possibly
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even both) of these regulatory processes. In the case of p53 the latter of the two mechanisms
(unnatural growth protection) is regulated. P53 is normally found in low levels, however, should
DNA damage be detected, the levels of this protein would rise and initiate the production of
proteins that halt cell division until the damage is repaired (Mora & Carbajo, 2008). If the
damage is too severe, however, p53 initiates the process of programmed cell death, or apoptosis,
which ultimately directs the cell to commit suicide thus permanently removing it from the invivo system (Mora & Carbajo, 2008). When p53 executes its function, it binds to regulatory
sites in the genome that in turn trigger the production of the aforementioned proteins such as
WAF1 and G1-S/CDK (Mora & Carbajo, 2008). In the case of WAF1 and G1-S/CDK, these two
proteins complex together which results in the affected cell being unable to proceed with the next
stage of cell division (Mora & Carbajo, 2008). As the name G1-S/CDK implies, cell growth is
usually halted at the G1/S phase by the complex that this protein participates in (Mora &
Carbajo, 2008). Due to the enormous benefit provided by p53, it is commonly given the nickname of tumor suppressor protein and guardian of the genome. In all, the role p53 plays in
neutralizing rogue cells is tantamount to the role of helper T cells in the immune system: both
identify harmful pathogens (the immune system “foreign” and p53 “domestic”) and both invoke
entities to do the actual neutralization of the target species.

As stated earlier, p53 binds to target regions/section of DNA that direct the transcription
and ultimate translation of proteins such as WAF1 and G1-S/CDK. Physically, this is
accomplished by the p53 tetramer opening up from its normally closed binding domain and
binding to the appropriate location on the gene (Mora & Carbajo, 2008). It is important to point
out however, that the structure to follow in Figure 20 does not bind to DNA. Figure 16 shows
the structure responsible for p53 chains binding to and amongst themselves for both the wild52

type and mutant strains. Malecka et al. reported the precise DNA binding residues (NOT the
tetramer binding region) as being the 99th residue to the 289th. The residues in Figure 16 (the
binding region studied in this work) span from 326th to the 356th residues. Thus below is an
image of the wild-type and mutant binding domains of the protein for inter-chain, intra-protein
stability which was also incidentally the structure used for this study (the chains are also
labeled). The accession number for the wild-type is 2J0Z and for the mutant it is 2J10.

Fig. 16: p53 binding domain, wild-type (16a) and mutant (16b). Accession numbers: 2J0Z and
2J10 respectively.

As can be seen, the tetramerization binding for this protein is a system of four alpha helices.
Each helix corresponds to and is attached to one of the monomers that make up the rest of each
monomer structure. As briefly mentioned earlier, the protein is flexible and it is in the binding
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domain that the flexibility is extremely important as this is the region wherein p53 binds to
DNA. This is unfortunately a problem for crystallographers as flexible proteins do not tend to
form orderly crystals, and if they do crystallize, the results are often of a low resolution (Malecka
et al., 2009). Structural determination has thus been mostly elucidated by piece-wise studies on
the protein, one of which is the binding domain featured in this study.

Mutations in p53 have a negative impact in the protein’s ability to carry out its function,
particularly, its immediate ability to effectively bind to DNA. The outcome of this impaired
reparatory ability is ultimately cancer. The human body is constantly being bombarded with
materials such as chemicals, ionizing radiation, that all have the potential to interact with DNA
and damage it (recall superoxide from mitochondrial respiration specially handled by SOD1). A
defective p53 will therefore not be able to invoke the proteins such as WAF1 and G1-S/CDK that
halt an affected cell thus allowing the growth of a tumor (Mora & Carbajo, 2008). In executing
its function it is noteworthy to mention that the p53 DNA binding domains interact primarily
with the major grooves of the DNA molecule (see Figure 19). The mutant strain that was
ultimately used sported two mutations at the 329th (T329F) and 331st (Q331K) positions not in
the DNA binding domain and was of the accession number 2J10 (Mora & Carbajo, 2008).

One of the unique scenarios presented by this particular case was its multiplicity of
chains (more than two) that required analysis. This presented an opportunity to study the binding
interactions present in the different combinations of chains to see what, if any trends could be
found. Thus the first module for p53 analysis focuses on the A-X chain family or combinations
(i.e. A-B, A-C and A-D). The other combinations will be considered later in their own separate
module reviews. For the overall Fine Parsing PPI analysis, the results are shown below,
54

Table 8: Fine Parsing Results for p53, A-B
WT

MUT

%

UL TOT:

-5.35E+01

-4.25E+01

21%

UCOUL TOT:

-3.04E+02

-2.60E+02

14%

5.89E-01

6.08E-01

3%

DISTANCE (AVG):

Table 9: Fine Parsing Results for p53, A-C
WT

MUT

%

UL TOT:

-1.56E+00

-1.10E+00

30%

UCOUL TOT:
DISTANCE (AVG):

-2.66E+01
8.04E-01

-3.59E+01
8.03E-01

26%
0.1%

Table 10: Fine Parsing Results for p53, A-D
WT

MUT

%

UL TOT:

-5.31E+00

-5.40E+00

2%

UCOUL TOT:

-6.87E+01

-7.81E+01

12%

6.97E-01

7.11E-01

2%

DISTANCE (AVG):

As can be seen, the overall Fine Parsing analysis yielded results that were relatively intuitive
given the structure of the binding domain. The A-B interactions (Table 8) yielded the greatest
total interaction quantities and smallest average separation distances among all the other
interaction pairs (A-C, A-D). The difference was one order of magnitude greater for the A-B
interactions compared against both A-C and A-D potentials. Average distances between wildtype and mutant strains, however, remained in the same order of magnitude for all three A-X
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interactions. One can see by visual inspection of Fig. 20 that in the overall structure, the greatest
inter-chain overlap indeed occurs between the A-B chains and, thus, the data corroborates that
these two chains certainly have the strongest interaction potentials. “Second place” in total
interaction potential went to the A-D chain interaction system with the next largest potentials and
smallest separation distances. Needless to say, A-C by far had the weakest interactions. When
tracking the shifts in potentials across the A-X chain family, we observe that there is an overall
decrease in in both Lennard-Jones and Coulombic potentials when going from the wild-type to
the mutant for the A-B chain interaction system. For the A-C pair, we see that there was a shift
from Lennard-Jones to Coulombic likewise when going from the wild-type to the mutant and for
the A-D chain interaction system there was an increase in Coulombic interactions.

Considering the associated Fine Parsing structure for these three interaction scenarios,
one can see that the mutated positions show up most predominantly in the A-B chain interactions
(Fig. 17). We can thus see that the mutated residues play an important role in binding for the
mutant strain and may account for the behavior noted the preceding discussion. The fine parsing
images for these results follow,
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Fig. 17: p53 wild-type (17a) and mutant (17b) Fine Parsing, A-B
Wild-type: 326-352 (A chain), 326-352 (B chain)
Mutant: 326-356 (A chain), 326-352 (B chain)

Fig. 18: p53 wild-type (18a) and mutant (18b) Fine Parsing, A-C
Wild-type: 336-344 (A chain), 336-344 (C chain)
Mutant: 335-343 (A chain), 335-343 (C chain)
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Fig. 19: p53 wild-type (19a) and mutant (19b) Fine Parsing, A-D
Wild-type: 343-354 (A chain), 343-354 (D chain)
Mutant: 339-355 (A chain), 342-354 (D chain)

From analyzing the above images, one can see that the A-B interaction system clearly had more
atoms participate in binding (so much that some degree of structure was even identified by DS
Viewer Pro©), thus accounting for the stronger overall interactions observed for the A-B system.
This stands in stark contrast to the fine parsing images for the A-C and A-D interactions that
clearly have fewer atoms participating in their binding and do not have any recognizable
associated structure. Additionally, one can see that atoms from both mutated residue positions
(the 329th and 331st residues) contributed to A-B interactions for both the wild-type and the
mutant, but only one select atom from the mutation at the 331st residue played any role in the AC and A-D binding and only for the mutant strain.
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Upon examination of the coarse parsing results, one can see that structurally, there is little
difference between the wild-type and the mutant. Although, as will be seen, there are some slight
differences with actual atomic orientations and angles, these differences manifest themselves
closer to the binding intra-protein, inter-chain domain of the tetramer and do not appear to be
overwhelmingly impactful on the overall morphology of the protein. Below are images taken
from these results,

Fig. 20: p53 wild-type (20a) and mutant (20b) coarse parsing, A-B
Wild-type: 326-352 (A chain), 326-352 (B chain)
Mutant: 326-356 (A chain), 326-352 (B chain)
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Fig. 21: P53 wild-type (21a) and mutant (21b) coarse parsing, A-C
Wild-type: 336-348 (A chain), 334-351 (C chain)
Mutant: 330-351 (A chain), 335-351 (C chain)

Fig. 22: P53 wild-type (22a) and mutant (22b) coarse parsing, A-D
Wild-type: 337-355 (A chain), 336-355 (D chain)
Mutant: 336-356 (A chain), 337-355 (D chain)
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When analyzing the common residue component of this system (common atom-atom pair
interactions for the A chain and X chain interactions), there are slight shifts in the total common
interaction potential values (Tables 14-16) with a slight weakening in A-B mutant interactions
over the wild-type strain. Chain interactions A-C and A-D experience a shift in Coulombic and
Lennard-Jones interactions respectively when going from the wild-type to the mutant.

Table 14: Common Results for p53 (A-B)
WT

MUT

%

UL TOT:

-2.12E+01

-1.83E+01

14%

UCOUL TOT:

-2.14E+02

-1.78E+02

17%

6.07E-01

6.37E-01

5%

DISTANCE (AVG):
COMMON ATOMATOM PAIRS:

428

Table 15: Common Results for p53 (A-C)
WT

MUT

%

UL TOT:

-6.80E-01

-7.02E-01

3%

UCOUL TOT:
DISTANCE (AVG):
COMMON ATOMATOM PAIRS:

-2.24E+01
8.27E-01

-2.55E+01
7.78E-01

12%
6%

42

61

Table 16: Common Results for p53 (A-D)
WT

MUT

%

UL TOT:

-1.67E+00

-2.13E+00

22%

UCOUL TOT:

-5.43E+01

-4.90E+01

10%

7.19E-01

7.22E-01

0.4%

DISTANCE (AVG):
COMMON ATOMATOM PAIRS:

105

However, for the uncommon interaction partners, the result is a dramatic shift from
Lennard-Jones to Coulombic interactions which on the whole is consistent with residue side
chain behavior given that the mutant has a Phenylalanine (non-polar) replacing a Threonine
(polar) and a Lysine (charged) replacing a Glutamine (polar). Thus in the end, the mutations
provide charged species that were lacking in the wild-type.

Table 17: Un-common Results for p53 (A-B)

UL TOT:
UCOUL TOT:
DISTANCE (AVG):
UN-COMMON
ATOM-ATOM PAIRS:

WT

MUT

%

-3.22E+01
-9.01E+01
5.74E-01

-2.42E+01
-8.15E+01
5.76E-01

25%
10%
0.4%

490

396

Table 18: Un-common Results for p53 (A-C)
WT

MUT

%

UL TOT:

-8.76E-01

54%

UCOUL TOT:
DISTANCE (AVG):
UN-COMMON
ATOM-ATOM PAIRS:

-4.20E+00
7.42E-01

-4.03E-01
1.04E+01
8.41E-01

16

27

60%
12%

62

Table 19: Un-common Results for p53 (A-D)

UL TOT:
UCOUL TOT:
DISTANCE (AVG):
UN-COMMON
ATOM-ATOM PAIRS:

WT

MUT

%

-3.64E+00
-1.44E+01
6.54E-01

-3.27E+00
-2.91E+01
7.00E-01

10%
51%
7%
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Given the participation of the mutated residues, it is interesting to note how the
interaction quantities compare from the wild-type to the mutant. Since the mutated position was
present in both the wild-type and mutant strains in the fine parsing of the A-B interaction system,
the following analysis was carried out. This was not the case with A-C and A-D however which
had a mutant residue position only show up in the mutant strain. The following three tables
present these findings,

Table 11: p53 Mutant Position Comparison (329 & 331)
WT

MUT

%

UL TOT:

-2.12E+01

-5.83E+00

73%

UCOUL TOT:

-1.44E+02

-5.05E+01

65%

5.77E-01

6.22E-01

7%

DISTANCE (AVG):

As can be seen, interactions are greater in the wild-type for both Lennard-Jones and Coulombic
interactions. As observed with the overall analysis previously discussed, the Coulombic
interactions are greater within the wild-type and this observation serves as a testament to the
nature of the forces that dominate in the endo-domain binding region of p53.
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The above analysis results were for the combined effects of both positions that exhibited
mutations. Considering now just the 329th position, one can see yet again the bias towards the
wild-type strain in having stronger interactions.

Table 12: p53 Mutant Position Comparison (329)
WT

MUT

%

UL TOT:

-1.80E+01

-2.37E+00

87%

UCOUL TOT:

-1.06E+02

-1.47E+01

86%

5.47E-01

5.73E-1

5%

DISTANCE
(AVG):

Interestingly enough, the average inter-atomic distances between wild-type and mutant
practically did not change. Even though the wild-type strain clearly had better interactions, once
again, we see the dominance of electrostatic forces as being considerably greater than LennardJones forces (electrostatic Coulombic interaction potentials were greater by an order of
magnitude).

Looking at the 331st position now, one can see an interesting turn of events for the
ranking of inter-atomic binding with the scenario now showing no preference for either strain,

Table 13: p53 Mutant Position Comparison (331)

UL TOT:
UCOUL TOT:
DISTANCE
(AVG):

WT

MUT

%

-3.24E+00
-3.85E+01

-3.46E+00
-3.58E+01

6%
7%

6.71E-01

6.45E-01

4%
64

Although there are practically no changes when going from one strain to another, one can
definitely see that the coulombic electrostatic forces predominate in both strains nonetheless.
This is interesting to note due to the fact that glutamine (present in the wild-type) is typically
treated and behaves as an uncharged amino acid in contrast to lysine (present in the mutant)
which is treated as a charged amino acid due to its side group. Nevertheless, the two amino acids
behave very similarly to each other as evidenced by the magnitude of their Lennard-Jones and
Coulombic interaction values.

Now that the A-X family of interactions has been described and discussed, we proceed to
the next module for consideration of the chain combination: B-X. Since the original
combinations for a quaternary chain system apply to only two members for the B-X family (B-C
and B-D), there are consequently only two combinations to look at now as opposed to the three
that there were for the A-X family (A-B, A-C and A-D). As before, the analysis for this family
will begin with the overall calculation results.

Table 20: Fine Parsing Results for p53 (B-C)
WT

MUT

%

UL TOT:

-3.74E+00

-7.15E+00

48%

UCOUL TOT:
DISTANCE (AVG):

-5.46E+01
7.24E-01

-8.33E+01
6.91E-01

34%
5%
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Table 21: Fine Parsing Results for p53 (B-D)
WT

MUT

%

UL TOT:

-2.48E+00

-1.25E+00

50%

UCOUL TOT:

-2.70E+01

-1.18E+01

56%

7.68E-01

7.81E-01

2%

DISTANCE (AVG):

As far as raw magnitudes are concerned, the B-C interaction system is definitely showing greater
attractions. Furthermore within B-C, one can see that the mutant version of the protein exhibits
greater interactions for both potentials. This is in contrast to the “second place” B-D system that
favors wild-type interactions (again, for both potentials). Interestingly enough, although the B-D
system is weaker overall, it nonetheless shows the most dramatic changes in potential
magnitudes going from the wild-type to the mutant when compared against B-C’s percent
differences. As has been typical thus far (with the exception of the uncommon results for the AC interactions) the distances have remained relatively constant and have not changed much
between wild-type and mutant strains.

Turning one’s attention to the fine parsing results, we can see that overall the distribution
of atoms in space responsible for binding is relatively the same among wild-type and mutant.
Overall residue participation was low, but slightly greater for the B-C system. Below are the
image results for this portion of the study,
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Fig. 23: P53 wild-type (23a) and mutant (23b) fine parsing, B-C
Wild-type: 343-354 (B chain), 343-354 (C chain)
Mutant: 342-354 (B chain), 343-354 (C chain)

Fig. 24: P53 wild-type (24a) and mutant (24b) fine parsing, B-D
Wild-type: 712-916 (B chain), 336-343 (D chain)
Mutant: 336-344 (B chain), 336-344 (D chain)
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Unlike in the A-X family, the mutated position (329 and 331) did not participate in binding in the
B-X family of interactions.

Like its predecessors in the A-X module, the coarse parsing for all B-X interactions
revealed that overall, the structure was generally well-preserved when going from the wild-type
to the mutant. Especially observed with the B-C interactions, some individual residue’s
constituent moieties and atoms did acquire novel orientations/positions in the mutant strain, but
apart from these slight details, there was little to suggest a major change in the structure
concerned with the quatramer’s intra-protein binding site. The images below detail these
observations,

Fig. 25: P53 wild-type (25a) and mutant (25b) coarse parsing, B-C
Wild-type: 337-356 (B chain), 337-355 (C chain)
Mutant: 337-356 (B chain), 337-355 (C chain)
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Fig. 26: P53 wild-type (26a) and mutant (26b), B-D
Wild-type: 336-351 (B chain), 335-351 (D chain)
Mutant: 336-351 (B chain), 336-351 (D chain)

Of a particularly interesting note was the slight reduction in alpha helical structure observed in
the B-D system for both mutants’ chains. Such a visual reduction further substantiates the fine
parsing evidence that the wild-type stain is more stable and exhibits stronger intra-protein
interactions. An item of note is the symmetry that the A-D chain interactions have with the B-C
chain interactions. Such a similarity is taken from the perspective of the coarse parsing results
for these two chains and is really not too surprising given the symmetry of the native protein.
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Table 22: Common Results for p53 (B-C)
WT

MUT

%

UL TOT:

-2.35E+00

-2.68E+00

12%

UCOUL TOT:
DISTANCE (AVG):
COMMON
ATOM-ATOM
PAIRS:

-4.59E+01
7.27E-01

-5.42E+01
7.16E-01

15%
2%

115

Table 23: Common Results for p53 (B-D)
WT

MUT

%

UL TOT:

-1.25E+00

-9.54E-01

24%

UCOUL TOT:

-8.08E+00

-8.78E+00

8%

7.94E-01

7.85E-01

1%

DISTANCE
(AVG):
COMMON
ATOM-ATOM
PAIRS:

23

The B-C system additionally showed that the mutant version of the protein was
particularly stronger than the wild-type across both interaction criteria (Lennard-Jones and
Coulombic). Thus the behavior of the common atom pairs were equal in their nature to the
behavior of all the atom pairs from the overall analysis. As seen the foregoing analyses prior to
the B-X family’s, virtually every residue that participated in binding for the overall analysis was
exactly represented in the analysis for common atom-atom interactions. There was some
deviation from this observation for the wild-type B-D case which had a total of eleven residues
present in binding interactions in the A chain alone. Out of these eleven residues, only five had
constituent atoms that participated in common interactions with the mutant strain. The B-D
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mutant strain by contrast had every single residue contribute to the common atom-atom
interactions which again was typical of every system studied thus far. As before, distance data
proved to conform more to typical values (between 7 to 9 dimensionless distance units).

Focusing on the uncommon results now, one can still see the B-C system reigning as the
chain interaction pair with the most influential binding compared against the B-D system. These
results are shown below,

Table 24: Uncommon Results for p53 (B-C)

UL TOT:
UCOUL TOT:
DISTANCE (AVG):
UN-COMMON
ATOM-ATOM PAIRS:

WT

MUT

%

-1.39E+00
-8.63E+00
7.15E-01

-4.47E+00
-2.91E+01
6.61E-01

69%
70%
8%

46

98

Table 25: Uncommon Results for p53 (B-D)
WT

MUT

%

UL TOT:

-1.23E+00

76%

UCOUL TOT:
DISTANCE (AVG):
UN-COMMON
ATOM-ATOM PAIRS:

-1.89E+01
7.55E-01

-2.95E-01
3.05E+00
7.74E-01

49

10

84%
2%

The B-C system clearly shows superior interactions in both potential types within the mutant
strain pertaining to a shift in interactions to both Lennard-Jones and Coulombic, just as it did in
the common analysis thus indicating a stronger, better bound mutant. The B-D system by
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contrast showed superior interactions in the wild-type strain with some considerable losses of
both these Lennard-Jones and Coulombic potentials in the mutant thus yielding weaker B-D
binding in the mutant.. The un-common analysis for the B-D interactions however proved to be
slightly different in that the Coulombic potential for the wild-type was now considerably greater
than its wild-type counterpart in the mutant strain (in contrast to the common analysis which
showed the Coulombic interactions to be relatively equal). Thus the end result for the B-X chain
interaction family is a small net overall change in the kinds of potentials present in those two
chain interaction systems.

The final module for p53 that is now thus addressed is the C-D interaction system. As
before, data for the overall analysis of the entire fine parsing output data file is shown below for
this system,

Table 26: Fine Parsing Results for p53 (C-D)
WT

MUT

%

UL TOT:

-5.92E+01

-5.31E+01

10%

UCOUL TOT:

-2.79E+02

-2.81E+02

1%

5.82E-01

5.91E-01

2%

DISTANCE (AVG):

As can be seen, the interaction parameters are relatively equal and thus do not change much
when going from the wild-type to the mutant. Of interesting note however is the rather short
distance (compared to the other analyses) that exists within both wild-type and mutant strains.
So far only the analysis for the mutated position at position 329 (see Table 12) has yielded
smaller values for inter-chain distances (5.47E-1 for the wild-type and 5.73E-1 for the mutant).
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The fine parsing images indicated the presence of both mutated positions as participants
in inter-chain binding between C and D for both the wild-type and mutant. This is reminiscent of
the mutated positions likewise showing up in the fine parsing for the A-B system. The images
showing these results are below,

Fig. 27: p53 wild-type (27a) and mutant (27b) fine parsing, C-D
Wild-type: 326-352 (C chain), 326-352 (D chain)
Mutant: 326-352 (C chain), 326-356 (D chain)

As has been seen throughout this study, virtually every single residue had atoms that participated
in fine parsing interactions. The only exceptions to this were the two mutated positions, 329 and
331, that are shown in the images above.
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Continuing with the coarse parsing, we can see that like all of the preceding structures,
the structure has been well-preserved and unchanged when going from the wild-type to the
mutant strain. As pointed out before, some atoms and moieties managed to get slightly moved in
orientation when introducing the mutations. As was observed with the A-X family, both
mutations were present in the coarse parsing structures as well. The images below showcase
these results,

Fig. 28: p53 wild-type (28a) and mutant (28b) coarse parsing, C-D
Wild-type: 326-356 (C chain), 326-355 (D chain)
Mutant: 326-356 (C chain), 326-356 (D chain)

Turning attention to the common interactions, we can see that there were virtually no
differences between the wild-type and mutant interaction pairs when going from one strain to
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another. To put it another way, wild-type and mutant C-D interaction chain behaviors were the
same.

Table 30: Common Results for p53 (C-D)
WT

MUT

%

UL TOT:

-2.76E+01

-2.84E+01

3%

UCOUL TOT:
DISTANCE (AVG):
COMMON ATOMATOM PAIRS:

-1.79E+02
6.09E-01

-1.83E+02
6.02E-01

2%
1%

471

When considering the un-common interactions, we see a relatively modest difference
between the wild-type and the mutant. In all, the only significant observable difference was the
wild-type losing Lennard-Jones interactions to the mutant by 22%, whereas the values for
Coulombic interactions and inter-atomic distances remained very close to each other across each
strain. The results are shown in the table below,

Table 30: Un-common Results for p53 (C-D)

UL TOT:
UCOUL TOT:
DISTANCE (AVG):
UN-COMMON
ATOM-ATOM PAIRS:

WT

MUT

%

-3.16E+01
-1.00E+02
5.57E-01

-2.47E+01
-9.82E+01
5.79E-01

22%
2%
4%

483

435

Thus the wild-type remains as the better bound system for the C-D interaction pairs with
Lennard-Jones interactions slightly going down in the mutated state.
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Since the mutated positions showed up like in the C-D chain interactions (see Fig. 27),
what follows now is an analysis that compares how the two residues behaved in terms of their
constituent atoms/ potentials and distances. Below are the results of this inquiry,

Table 27: Mutant Position Comparison (329 & 331)
WT

MUT

%

UL TOT:

-6.76E+00

-6.77E+00

0.1%

UCOUL TOT:

-6.55E+01

-4.78E+01

27%

DISTANCE (AVG):

6.33E-01

5.80E-01

8%

Remarkably enough, the results from all of the constituent atoms for both mutated positions
behaved almost identically. Only the wild-type exhibited a considerable decrease in its
Coulombic interactions (thus the wild-type was better bound) with the two values differing by
27%. As before, the distances remained very close to each other.

Focusing now on just the 329th residue position, we begin to see some deviation in
potential behavior. These results are in the table below,

Table 28: Mutant Position Comparison (329)
WT

MUT

%

UL TOT:

-3.22E+00

-4.50E+00

28%

UCOUL TOT:
DISTANCE (AVG):

-5.37E+01

-1.63E+01

5.95E-01

4.99E-01

70%
16%

Although the wild-type showed considerably stronger Coulombic interactions, the mutant strain
ultimately displayed the most varied changes in the form of Lennard-Jones interactions
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increasing, and the inter-atomic distances decreasing, all of which are hallmarks of improved and
stronger interactions. The sharp decrease observed in the Coulombic interactions going from the
wild-type to the mutant is consistent with what is known from the identity of the missense
mutation covered here: the wild-type 329th residue is threonine which is a polar amino acid and it
is replaced by a phenylalanine which is a non-polar amino acid. It thus makes sense that the
polar influence should decrease given its replacement with something non-polar. In terms of
distance, this was one of the few instances where the distance parameter changed noticeably, and
for this case, it changed in favor of the mutant (the mutant is now closer among its chains).

Lastly, we now turn to the 331st mutated residue position. When considering only this
position, the results indicated that the wild-type had superior interactions in both potentials and
no changes to inter-atomic distances were observed. These results are shown below,

Table 29: Mutant Position Comparison (331)

UL TOT:
UCOUL TOT:
DISTANCE (AVG):

WT

MUT

%

-3.54E+00
-3.87E+01
6.57E-01

-2.27E+00
-3.15E+01
6.57E-01

36%
19%
0%

Thus in all, one can see a wide variation of results for the different combinations of
chains, even when they are within the same protein. In some cases the common interactions for
the different strains are truly carbon copies of each, which is intuitive and makes sense, but in
other scenarios, they are different enough to warrant further investigation using additional tools
such as dynamic studies. For p53, it can thus be concluded that mutations have a competing (i.e.
Lennard-Jones increasing but Coulombic decreasing at the same time) effect although weakening
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the structure somewhat. The changes observed are not dramatic enough to prevent the tetramer
from binding amongst its constituent chains, but they are sufficient to alter its binding ability to
DNA.

5.3 SYSTEMS ANALYZED: HRAS

The next system analyzed was for another protein with strong associations with cancer
(akin to p53): HRAS. The HRAS protein is made of a 21.45 kDa single chain (“Hras (human),”
2014) unlike the other protein systems analyzed thus far (which had two or more chains) so in
this respect, its analysis approach was unique and required a novel consideration that was
unnecessary before for the other systems (more on this later). Below is an image of HRAS wildtype that was employed for this study (accession number 4EFL) (Muraoka, Shima, Araki, & et
al., 2012),

Fig. 29: HRAS wild-type (29a) and mutant (29b)

HRAS is a protein responsible for the regulation of cell division and cell growth. The
regulation itself is triggered in response to growth factor stimulation (Muraoka et al., 2012).
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Growth factors are a class of chemicals, namely, cytokines, hormones and proteins that positively
affect cell growth and development (Muraoka et al., 2012). It is typically from an extracellular
environment that HRAS interacts with these compounds and thus HRAS is usually associated
with cell membranes due to the presence of an isoprenyl group on its C-terminus (Muraoka et al.,
2012). Once the appropriate cell signals have been received, stimulation of signal transduction
events by means of recruiting additional proteins such as c-Raf and PI 3-kinase within the
cytoplasm direct the cell to continue growing and divide (a transduction event is the process by
which proteins and secondary messengers relay signals from the outside of the cell to the cell
nucleus) (Muraoka et al., 2012). Thus HRAS responds in an agonistic manner in response to the
growth factors and is an early player in this particular cell signaling chain of command given its
position at the front end of the process. The specific mechanism by which HRAS accomplishes
its function in relaying the appropriate message in response to growth factor (or the absence
thereof) is the enzymatic cleavage of GTP (guanosine triphosphate) to GDP (guanosine
diphosphate) (Muraoka et al., 2012). When HRAS is bound to GDP, the protein is said to be off
and it will not recruit downstream proteins to execute cell division. When HRAS is bound to
GTP however, the protein is said to be on and instructions to carry out cell division and growth
will be conveyed to the nucleus (Muraoka et al., 2012). Thus the process of turning HRAS “on”
involves the enzymatically assisted hydrolysis of GTP to GDP specifically removing a phosphate
group from the 5’ carbon of the ribose sugar, and turning the protein “off” involves the rephosphorylation of GDP to GTP accomplished with the help of pyruvate kinase, a
phosphorylating enzyme (Muraoka et al., 2012).
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With respect to the binding site of this protein, there are technically two, but only one is
specifically involved in the pathology associated with aberrant HRAS forms. The image below
details these binding sites as reported by Miyakawa, Morikawa, Takasu, & et al., 2013,

Fig. 30: HRAS binding sites, GDP complex (off)

With regards to the GTP/GDP dependency of the on/off status of HRAS, the loop in Figure 45
labeled as Switch I houses the GTP/GDP molecule mentioned earlier (Miyakawa et al., 2013).
The second loop, called Switch II, in turn houses a molecule of water for the de-phosphorylation
of GTP via hydrolysis (Miyakawa et al., 2013). When a mutation manifests itself in HRAS, the
danger lies in how that mutation will affect the Switch I loop (Franken, Scheidig, Krengel, & et
al., 1993). If the mutation should result in the “on” position (GTP bound state) remaining as a
permanent state by preventing the normal enzymatic hydrolysis activity, then cancer may very
well result due to the perpetual signal for the cell to grow and multiply (Franken et al., 1993).
Thus wherein the danger with mutated p53 was in growth no longer being halted, the danger
with mutated HRAS is that growth is now permitted excessively. Should HRAS be negatively
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affected by a congenital mutation, then the result may be what is known as Costello syndrome
(named after the New Zealand pediatrician who first reported this disorder to the Australian
Paediatric Journal) (Franken et al., 1993). This disease is characterized by delayed development,
mental retardation, cancerous (and non-cancerous) tumors, distinctive facial features, unusually
flexible joints and heart abnormalities such as tachycardia (an extremely fast heartbeat) (Franken
et al., 1993). Although the tumors are explained via the function of HRAS, researchers are as of
yet still unsure as to how the other disease characteristics (especially mental retardation)
manifest from aberrant HRAS production. The most common mutation resulting in Costello
syndrome replaces the amino acid glycine at the twelfth position with serine (Franken et al.,
1993). The mutation that was employed for this study replaced glycine at this same position but
with aspartic acid instead (mutant accession number: 1AGP) (Franken et al., 1993). Both strains,
wild-type and mutant, were in the “on,” GTP bound state. The final location chosen was the 57th
residue such that the first “sub” chain of HRAS would contain Switch I and the second “sub”
chain would contain Switch II. Thus the first “sub” chain contained residues 1-57 and the second
“sub” chain contained the residues 58-166 which marked the end of the HRAS chain. The image
below shows this demarcation with the 57th residue hi-lighted in dark blue,
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Fig. 31: HRAS splitting location

Table 30 shows the overall analysis for the Fine Parsing of the HRAS system as
described above. We can see that the mutant strain had better binding interactions. Although
both Lennard-Jones and Coulombic forces increased, the attractive Coulombic interactions
increased the most when going from the wild-type to the mutant.

Table 30: Fine Parsing Results for HRAS
WT

MUT

%

UL TOT:

-8.02E+01

-9.07E+01

12%

UCOUL TOT:

-3.81E+02

-4.98E+02

23%

6.09E-01

6.06E-01

0.5%

DISTANCE (AVG):

The first thing worth mentioning when considering the Fine Parsing images (Fig. 32) for
the overall analysis of this system is that the specific arrangement of atoms in space changes
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somewhat noticeably when going from the wild-type to the mutant strain. The other detail
worthy of note is that the mutated residue position appears in the Fine Parsing Results for both
strains and is therefore a direct participant in the interactions between Switch I and Switch II
domains.

Fig. 32: HRAS wild-type (32a) and mutant (32b) Fine Parsing, sub-chains: 1-57 & 58-166
Wild-type: 1-57 (sub-chain 1-57), 58-165 (sub-chain 58-166)
Mutant: 1-57 (sub-chain 1-57), 58-165 (sub-chain 58-166)

It is interesting to note that despite the seemingly different arrangement of the atoms in the
mutant compared against the wild-type, the data discussed in the foregoing paragraph
nonetheless indicate that average inter-chain atomic distances remained virtually identical.
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As can be seen from the coarse parsing analysis (Fig. 33), the Switch I loop is missing
from the wild-type structure but is present in the mutant. Thus OpenContact’s © results indicate
that there indeed is a difference involving structure between the wild-type and the mutant to the
conclusion that the Switch I loop in the mutant is more proximal to the Switch II loop than in the
wild-type strain. This is consistent with the known pathological characteristics of mutated
HRAS where the GTP in Switch I is negatively affected by somehow being shielded from dephosphorylation hydrolysis (which is what should happen) thus leaving GTP permanently
unchanged in the Switch I loop. This may lead to the observed rampant cellular growth and
division associated with the mutant strain.

Fig. 33: HRAS wild-type (33a) and mutant (33b) coarse parsing, sub-chains: 1-57 & 58-166
Wild-type: 1-57 (sub-chain 1-57), 58-166 (sub-chain 58-166)
Mutant: 1-57 (sub-chain 1-57), 58-166 (sub-chain 58-166)

When considering the common interaction partners (Table 32), we can see that there is
very little variation between the wild-type and mutant strains again.
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Table 32: Common Results for HRAS
WT

MUT

%

UL TOT:

-5.98E+01

-5.59E+01

7%

UCOUL TOT:

-3.46E+02

-3.50E+02

1%

6.08E-01

6.11E-01

1%

DISTANCE (AVG):
COMMON ATOMATOM PAIRS:

937

When considering the un-common interactions (Table 33), we see a shift in interactions
going in favor of the mutant, with a rather substantial increase, specifically in the Coulombic
attractive interactions.

Table 33: Un-common Results for HRAS

UL TOT:
UCOUL TOT:
DISTANCE (AVG):
UN-COMMON ATOMATOM PAIRS:

WT

MUT

%

-2.04E+01
-3.49E+01
6.17E-01

-3.48E+01
-1.48E+02
5.99E-01

41%
76%
3%

278

574

Thus when comparing the uncommon atom-atom interaction pairs to the common interaction
pairs, it can be seen that the changes effected to the mutant (of most importance to the Switch I
loop) entirely come from the uncommon interactions. Furthermore, these uncommon
interactions are considerably stronger for the mutant thus indicating that whatever hindrance is
imposed upon GTP in the Switch I loop stems from an inherently in-flexible loop that does not
permit the catalytic cleavage that this enzyme is supposed to execute.
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An interesting result that had not been observed thus far was that although out of all the
wild-type’s residues, each participated in common binding (except the position that was to be
mutated of course), the mutant itself had five extra residues that did not participate at all in
common interactions with the wild-type strain. These extra residues in the mutant that were
foreign to the wild-type’s binding were residues 27-30. The wild-type strain thus exhibited 48
residue interactions and the mutant 53.

Upon close inspection and comparison of the mutated residue in the wild-type and
mutant, one can see that they are both remarkably similar. The only real difference is a modest
gain in Lennard-Jones interactions by the mutant which is curious in that the aspartic acid that
defines the mutant is charged, more so than the glycine in the wild-type. Thus one would expect
an increase in Coulombic interactions, but reality defied this expectation. The results are
presented in the table below,

Table 31: Mutant Position Comparison (12)
WT

MUT

%

UL TOT:

-1.22E+00

-1.67E+00

27%

UCOUL TOT:

-8.80E+00

-8.73E+00

1%

2.21E+01

2.02E+01

9%

DISTANCE (AVG):

As has become a hallmark of these systems, the distance remained unchanged is the closest by
far among the specific cases wherein a mutated residue position participated in binding.
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5.4 SYSTEMS ANALYZED: DHFR

The next system protein studied was the 21.45 kDa, enzyme dihydrofolate reductase, or
DHFR (“DHFR (human),” 2014). Like HRAS, this protein was also a one chain monomeric
system. The wild-type structure that was employed for this study was of the accession number
1DRF (Oefner, D’Arcy, & Winkler, 1988).

DHFR is an enzyme produced in the liver that is responsible for the reduction of
dihydrofolic acid to tetrahydrofolic acid using the cofactor nicotinamide adenine dinucleotide
phosphate (NADPH) as an electron donor (see image below),

Fig. 34: NADPH with DHFR-relevant moieties

Tetrahydrofolic acid is an important precursor in the in-vivo bio-synthesis of purines and
pyrimidines which in turn serve as the building blocks of DNA and RNA (Oefner, D’Arcy, &
Winkler, 1988). DHFR thus serves as a catalyst for the important building blocks of genetic
material and it is therefore found in every dividing cell, eukaryotic or otherwise. The mechanism
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of enzymatic activity was stated by Oefner et al. as being the transfer of a hydride from NADPH
to dihydrofolate with an accompanying protonation to produce tetrahydrofolate. As will be
explored in more detail shortly, an important location on this protein known as the Met20 loop
helps to stabilize the nicotinamide ring of the NADPH (see Figure 52) to promote the transfer of
the hydride from the NADPH to the dihydrofolate (Ulrich, Akutsu, Doreleijers, & et al., 2014) .

DHFR is generally divided into two major sub-domains: the adenosine-binding subdomain and the loop sub-domain (Cario , Smith, Blom, & et al., 2011). The adenosine-binding
subdomain is the larger of the two and it binds the adenosine moiety of NADPH (see Figure 52)
(Cario et al., 2011). The loop sub-domain contains three loops, the Met-20 loop (mentioned in
the foregoing paragraph), the F-G loop and the G-H loop (Ulrich et al., 2014). In between these
two sub-domains lies a long groove structured by a large beta sheet and an alpha helix which is
the active site where folate and NADPH bind together (Ulrich et al., 2014). The overall location
of these structures and the active site is shown in the following image as reported by Ulrich et al.,

Fig. 35: DHFR wild-type with ligand binding domains (35a) and mutant (35b).
Cleavage site: VAL112. Wild-type accession number: 1DRF, mutant accession number: 3EIG.
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As will be expounded upon shortly, the binding behavior of this protein that can affect human
health is the binding of NADPH to DHFR (Oefner et al., 1988).

Should mutations occur near or on the loop sub-domain, DHFR may have problems
adequately binding to NADPH, specifically, the nicotinamide moiety (Volpato, Yachnin,
Blanchet, & et al., 2009). As reported by Ulrich et al., the Met 20 loop regulates NADPH
binding by being flexible and allowing the cofactor access to its binding site. Thus mutations
that affect the loop sub-domain, specifically the Met 20 loop, may have negative consequences in
DHFR even binding to its NADPH ligand and carrying out its function. If such a congenital
mutation were to manifest itself, a disorder known as megaoloblastic anemia can occur (Volpato
et al., 2009). In this disorder, a deficiency of tetrahydrofolate (the product of DHFR and
dihydrofolate) results in inadequate DNA synthesis for red blood cell production (Volpato et al.,
2009). When DNA synthesis is impaired, the cell cycle cannot continue beyond the G2 growth
stage to the M (mitosis) stage. Thus a common hematological trademark of megaloblastic
anemia are (as the name “megaloblastic” might imply) abnormally large and dysfunctional red
blood cells in the bone marrow. Like many other kinds of anemia, symptoms of this variety of
the disease are fatigue, weakness, difficulty concentrating and general malaise (Volpato et al.,
2009). For this study, a mutant strain was analyzed with two mutations: F31R and Q35E These
mutations were both located on the alpha helix superior to the loop sub-domain. The mutant’s
accession number was 3EIG (Volpato et al., 2009). Since DHFR is a monomeric protein, it had
to be cleaved in order to feed it to OpenContact©. The location of thus breaking the pdb file was
position 112 and it was so chosen so that the two sub-domain NADPH binding regions would be
separate (see Figure 35).
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The results for the overall Fine Parsing analysis of this system showed that the mutant
had gained Lennard-Jones interactions, although the gain was relatively modest. The table below
details these results,

Table 32: Fine Parsing Results for DHFR

UL TOT:
UCOUL TOT:
DISTANCE (AVG):

WT

MUT

%

-1.31E+02
-4.56E+02
5.87E-01

-1.53E+02
-4.77E+02
5.79E-01

14%
4%
1%

The pictorial fine parsing results for DHFR show that overall three-dimensional binding
atom distribution remained relatively constant between the two strains. Of note was that residues
of the Met 20 loop were present in the fine parsing files for both strains indicating that it did play
a direct, significant role in intra-protein interactions. The Met 20 loop region is encircled in
yellow in the Fig. 36.
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MET20 LOOP REGION

MET20 LOOP REGION

Fig. 36: DHFR wild-type (36a) and mutant (36b) Fine Parsing, sub-chains: 1-112 & 113-186
Wild-type: 2-112 (sub-chain 1-112), 113-184 (sub-chain 113-186)
Mutant: 2-112 (sub-chain 1-112), 113-184 (sub-chain 113-186)

Also 31st residue position that was ultimately mutated, played a role in the wild-type and mutant
interactions. It was also observed that every residue that participated in fine parsing interactions
had constituent atom-atom pairs that were common to both strains.

When considering the coarse parsing structures, we can see that the mutant strain
acquired more structure in that it now has an additional helix that did not play a role in the wildtype. Apart from this detail, the remainder of the structure was identical. The images are below,
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Fig. 37: DHFR wild-type (37a) and mutant (37b) coarse parsing, sub-chains: 1-112 & 113-186
Wild-type: 1-112 (sub-chain 1-112), 113-186 (sub-chain 113-186)
Mutant: 1-112 (sub-chain 1-112), 113-186 (sub-chain 113-186)

Again, as in the fine parsing image results, the 31st residue showed up as a structural participant
in both strains. The 35th position also showed up here, though not in the fine parsing results.

The common results showed practically no variation between the wild-type and the
mutant. These results are in the table below,

Table 36: DHFR Common Results

UL TOT:
UCOUL TOT:
DISTANCE (AVG):
COMMON ATOMATOM PAIRS:

WT

MUT

%

-1.02E+02
-4.79E+02
5.97E-01

-1.06E+02
-4.89E+02
5.90E-01

4%
2%
1%

1427
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The results for the un-common interactions indicated a curious balance between LennardJones interactions and Coulombic repulsion. Both strains have an attractive Lennard-Jones
criterion and repulsive Coulombic interactions. Of particular note was the dominant shift in
Lennard-Jones interactions that the mutant strain exhibited compared to the wild-type (the wildtype had a Lennard-Jones to Coulombic ratio of approximately 1.2 compared to the mutant
which had a Lennard-Jones to Coulombic ratio of around 3.9).

Table 37: DHFR Un-common Results

UL TOT:
UCOUL TOT:
DISTANCE (AVG):
UN-COMMON ATOMATOM PAIRS:

WT

MUT

%

-2.84E+01
2.29E+01
5.36E-01

-4.62E+01
1.20E+01
5.44E-01

39%
48%
1%

281

447

The results for comparing the behavior of both the wild-type and mutant residue (position
31) yielded results that indicated that the mutant strain of the protein had superior binding
potentials compared to the wild-type. The table below summarizes these results,

Table 34: DHFR mutant position (31)

UL TOT:
UCOUL TOT:
DISTANCE (AVG):

WT

MUT

%

-9.35E-03
-1.39E+00
8.97E-01

-2.60E-02
-2.18E+00
7.75E-01

64%
36%
14%
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As was observed with the overall analysis, the mutant residue showed the steepest increase in
Lennard-Jones potentials which seems counter-intuitive. The expectation of the mutant’s
charged arginine amino acid would be that it should have a greater increase in Coulombic
interactions than the wild-type.

5.5 SYSTEMS ANALYZED: HUNTINGTIN

The final protein analyzed in this study was the huntingtin protein (HTT). It is a trimer
protein (a three chain system) with each monomer having a molecular weight of 347.60 kDa for
a total of 1042.8 kDa for the whole, biologically active protein (“Huntingtin (human),” 2014).
As the name suggest, this protein is implicated in Huntington’s disease, a neurodegenerative
disorder. Due to the extreme difficulty in crystallizing this protein, the following structure below
for the wild-type strain of what was studied is only of the structure of the N-terminal region
(accession number 3IO4),
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Fig. 38: HTT wild type N-terminus (38a) and mutant (38b)
Wild type accession number: 3IO4
Mutant accession number: 4FE8

It is important to note that the pdb file corresponding to the above image was of the Huntingtin
protein’s N-terminus stabilized by a maltose binding protein to help retain structural stability
during crystallization (Kim, Chelliah, Kim, Otwinowski, & Bezprozvanny, 2009). This maltose
binding protein was manually omitted for the study however and only this segment of the
huntingtin protein was subjected to analysis. As with p53, this system involved considering the
interactions from the different combinations of chain interaction partners (i.e. A-B, A-C, etc…).

Huntingtin is an elusive protein in that its exact role in vivo is not clearly understood
(Kim et al., 2009). Experiments with transgenic mice where the gene that encodes for huntingtin
has been deleted (knockout) have proven lethal to the rodents (Kim et al., 2009). This protein is
highly expressed in neurons and testes of both humans and rodents and interestingly, it has no
sequence homology with any other protein (Kim et al., 2009). Huntingtin has also been shown
to upregulate the expression of the nerve factor Brain Derived Neurotrophic Factor (BDNF) at
the transcription level, but the exact mechanism of how this is accomplished is not known either
(Kim et al., 2009). From various experiments in electron microscopy and
immunohistochemistry, it has been found that Huntingtin is primarily associated with the intracellular machinery of vesicles and microtubules (Kim et al., 2009).

Although Huntingtin is known to interact with many proteins in the human body (most
famously the Huntingtin Interacting Protein or HIP), due to its presently unknown mechanism of
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function, there is really no active site to presently report of for this protein (although the protein
itself is ubiquitously found in the cytoplasm of cells) (Kim et al., 2009). Thus the perspective of
this study will instead focus on a unique aspect of mutated Huntingtin’s pathology: a longer than
normal polyglutamine segment (known as a polyglutamine expansion) that is associated with
Huntingtin aggregates in infected systems (Kim, 2013). Huntingtin’s disease occurs when the
polyglutamine expansion exceeds 36 glutamines near the amino terminus although the cellular
mechanisms that link this expansion to disease manifestation is still under investigation (Kim,
2013). The following image shows the location of the polyglutamine region in the mutant strain
that was studied (accession number 4FE8) (Kim, 2013). This mutant strain had thirty-six
glutamine residues,

Fig. 39: Huntingtin mutant (accession number: 4FE8)
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The glutamine expansion region starts with the 388th residue (Kim, 2013). It is important to note
that not all thirty-six glutamines in the polyglutamine region were captured by the
crystallographic experiment that yielded the above structure. As one can envision from the C
chain however (which presented the most complete polyglutamine region), the polyglutamine
region would simply extend all three chains in the figure’s triangular configuration outward.
How this extension would affect inter-chain binding (if it affects it at all) is the subject of this
study. With respect to pathology, most evidence is consistent with the hypothesis that the
expanded protein acquires a “toxic gain of function (Kim, 2013).” Apart from the aggregates,
other toxic properties incumbent on expanded Huntingtin have been observed to be negative
effects on gene transcription, induction of apoptosis, and disruption of key neuronal functions
such as axonal transport, synaptic transmission, and Ca+2 signaling (Kim, 2013). As stated by
Kim et al., 2009, “many of the proposed mechanisms suggest that expanded Huntingtin is
involved in pathological interactions with other signaling proteins in cells, leading to neuronal
dysfunction and death.” The mutant strain studied was a form of Huntingtin with thirty-six
glutamines: pdb accession number: 4FE8.

The first combination that will be considered in the overall analysis is the A-X family of
chains. As can be seen from Tables 38 and 39, there were some substantial shifts in the nature of
the potentials that dominated between the wild-type and the mutant. In general, the most
dramatic changes were observed to take place between the A-C chain interactions.
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Table 38: Fine Parsing Results for Huntingtin (A-B)
WT

MUT

%

UL TOT:

-7.83E+00

-3.31E+00

58%

UCOUL TOT:

-1.32E+01

-1.24E+01

6%

5.57E-01

6.42E-01

13%

DISTANCE (AVG):

Table 39: Fine Parsing Results for Huntingtin (A-C)

UL TOT:
UCOUL TOT:
DISTANCE (AVG):

WT

MUT

%

-8.20E+00
-8.86E+00

-3.05E+00
-1.11E+01

63%
20%

5.68E-01

6.45E-01

12%

In the A-B interactions there was an overall reduction in the attractive forces in going from wildtype to mutant whereas in A-C, there were compensating effects of decreases in Lennard-Jones
attractions and increases in Coulombic attractions. An interesting item of note is that the
presence of a polyglutamine region in the mutant apparently creates more distance between the
chains for both strains (the mutant average distance is longer in both). In general though, the
similarity between A-B and A-C is not too surprising given the near equilateral triangular
geometry that Huntingtin’s N-terminus (see Figure 58).

Considering the pictorial representation for the fine parsing results (Fig. 40), we can see
that the polyglutamine region participated in binding effects for the A-B wild-type interactions,
but not for for the A-B mutant despite its expanded role in the mutant.
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Fig. 40: Huntingtin wild-type (40a) and mutant (40b) Fine Parsing, A-B
Wild-type: 373-413 (A chain), 371-391 (B chain)
Mutant: 372-384 (A chain), 371-377 (B chain)

Fig. 41: Huntingtin wild-type (41a) and mutant (41b) Fine Parsing, A-C
Wild-type: 371-412 (A chain), 371-384 (C chain)
Mutant: 371-377 (A chain), 372-384 (C chain)
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No presence of the glutamine region was found in the any of the A-C interactions, wild-type or
mutant (Fig. 41).

The coarse parsing results showed that the wild-type of both A-B and A-C chains had
more secondary structure than the mutant which is consistent with the increased atom-atom
separation distances (Figs. 42 and 43). The A-B and A-C chain wild-types furthermore had the
polyglutamine region participating in structure. Only the A-C system’s mutant had the
polyglutamine region however. These results are presented in the images below,

Fig. 42: Huntingtin wild-type (42a) and mutant (42b) coarse parsing, A-B
Wild-type: 372-415 (A chain), 371-395 (B chain)
Mutant: 372-388 (A chain), 371-381 (B chain)
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Fig. 43: Huntingtin wild-type (43a) and mutant (43b) coarse parsing, A-C
Wild-type: 371-413 (A chain), 371-391 (C chain)
Mutant: 371-381 (A chain), 372-391 (C chain)

Looking at the common atom-atom interaction results from the Fine Parsing data (Tables
40 and 41), we see, first of all, that the A-B interaction system was not truly affected in any
meaningful way. For the A-C chain system however, we see that the mutant results were
significantly different from the wild-type even for the same of common atom-atom pair
interactions.

Table 40: Common Results for Huntingtin (A-B)
WT

MUT

%

UL TOT:

-8.20E-01

-7.77E-01

5%

UCOUL TOT:

-9.34E+00

-9.05E+00

3%

6.94E-01

6.95E-01

0.2%

DISTANCE (AVG):
COMMON ATOMATOM PAIRS:

23
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Table 41: Common Results for Huntingtin (A-C)
WT

MUT

%

UL TOT:

-6.77E-02

-1.43E-01

53%

UCOUL TOT:

-5.37E+00

-6.77E+00

21%

8.22E-01

7.54E-01

8%

DISTANCE (AVG):
COMMON ATOMATOM PAIRS:

14

Upon studying the un-common results for the A-X family, we first of all see that both
inter-chain interaction systems (A-B and A-C) were indirectly affected by the polyglutamine
expansion region when going from the wild-type to the mutant. The un-common atom-atom
pairs are not directly associated with the additional residues of the mutant (Fig. 41). We
additionally see that the A-B system’s mutant attractive interactions were diminished over the
wild-type strain with a concomitant increase in inter-atomic distances.

Table 42: Un-common Results for Huntingtin (A-B)
WT

MUT

%

UL TOT:

-7.01E+00

-2.53E+00

64%

UCOUL TOT:

-3.90E+00

-3.34E+00

14%

5.07E-01

6.03E-01

16%

DISTANCE (AVG):
UN-COMMON
ATOM-ATOM PAIRS:

62

31
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Table 43: Un-common Results for Huntingtin (A-C)
WT

MUT

%

UL TOT:

-8.13E+00

-2.91E+00

64%

UCOUL TOT:

-3.49E+00

-4.38E+00

20%

5.21E-01

6.06E-01

14%

DISTANCE (AVG):
UN-COMMON ATOMATOM PAIRS:

76

39

The A-C pair was more varied in that its wild-type had better Lennard-Jones potentials and
distance, but the mutant version had stronger Coulombic interactions.

Finally we turn our attention to the B-X family of interactions which for this case, only
contained one member: B-C. The overall results for B-C are as follows,

Table 44: Fine Parsing Results for Huntingtin (B-C)

UL TOT:
UCOUL TOT:
DISTANCE (AVG):

WT

MUT

%

-6.85E-01
-9.37E+00

-3.08E+00
-1.03E+01

78%
9%

7.86E-01

6.32E-01

20%

As can be seen, the mutant version of the protein has considerably better attractive interactions
than the wild-type, specifically with respect to the Lennard-Jones potential and distance. Of
interest was the dramatic increase (78%) of binding due to Lennard-Jones interactions for the
mutant which was higher than any of the Lennard-Jones potential increases observed in the A-X
family.
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Looking at the Fine Parsing image results, we can see that the mutant strain has greater
numbers of atom-atom interaction partners compared to the wild-type. In addition, these binding
atoms are even more densely arranged for the mutant than for the wild-type which is (at least
from a qualitative perspective) consistent with the data from Table 44.

Fig. 44: Huntingtin wild-type (44a) and mutant (44b) Fine Parsing, B-C
Wild-type: 372-383 (B chain), 371-374 (C chain)
Mutant: 372-384 (B chain), 371-377 (C chain)

Coarse parsing image results show an overall retention of structure when going from the
wild-type to the mutant. Detailed inspection of the two structures, however, shows that the
mutant strain has slightly developed more structure than the wild-type. This development of
structure is indicative of greater stability for the mutant which is hinted at in Table 44 by the
increase in Lennard-Jones interactions and a decrease in average inter-atomic distance.
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Fig. 45: Huntingtin wild-type (45a) and mutant (45b) coarse parsing, B-C
Wild-type: 372-391 (B chain), 371-381 (C chain)
Mutant: 372-391 (B chain), 371-381 (C chain)

The results for the common atom-atom pair interactions likewise indicated that the
mutant strain had somewhat stronger attractive interactions, although the distances changed
negligibly (Table 45).

Table 45: Common Results for Huntingtin (B-C)
WT

MUT

%

UL TOT:

-3.47E-01

-4.88E-01

29%

UCOUL TOT:

-7.38E+00

-8.69E+00

15%

7.77E-01

7.36E-01

5%

DISTANCE (AVG):
COMMON ATOMATOM PAIRS:

21
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With the un-common interactions, it was observed that the Lennard-Jones potential
increased when going from the wild-type to the mutant quite dramatically (by 87%) and the
Coulombic potential decreased, but not as sharply (only 21%).

Table 46: Un-common Results for Huntingtin (B-C)
WT

MUT

%

UL TOT:

-3.37E-01

-2.60E+00

87%

UCOUL TOT:

-2.00E+00

-1.58E+00

21%

8.04E-01

5.54E-01

31%

DISTANCE (AVG):
UN-COMMON
ATOM-ATOM PAIRS:

10

28

The dramatic increase in the Lennard-Jones potential for the mutant, however, was also
accompanied by a decrease in average inter-atomic distance.

6.0 RESULTS AND DISCUSSION

This study proved very insightful in terms of the behavior that many seemingly unrelated protein systems exhibited. As it turned out (and this occurred purely by coincidence), the
six systems could be broken down into three main groups (where each group contained two
protein systems), where each group was defined by a certain set of characteristics. Those three
groups were originally identified by whether or not the biological activity of the protein was
affected by the mutation(s). Other criteria were soon discovered to adhere to a trend marked by
characteristics such as acquisition of additional secondary structure by the mutant and number of
chains of the biologically active protein. It is important to note that although these observations
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may hint at a potential classification system for intra-protein behavior, the study of additional
systems is necessary to determine if classification can indeed be obtained. These observations
are shown in Table 47.

Table 47: Potential PPI Organization Scheme

CLASS1
CLASS2
CLASS3

TRANS
SOD1
DHFR
HRAS
P53
HUNT

Biology
affected?
No
No
Yes
Yes
Yes
Unknown

Mutant gains
secondary
structure?
No
Yes
Yes
Yes
No
No

Strain favored
by potential
shift?
Mutant
Neither
Mutant
Mutant
Wild Type
Wild Type

Number of
chains?
4
2
1
1
4
3

Total
number of
ligands?
3
2
2
2
1
Unknown

These results were compiled from the overall Fine Parsing analyses of each system. For ease of
comparison, these specific Fine Parsing results are in the appendix, Figs. B1-B6. Thus there may
be a paradigm that unifies protein systems of diverse functions which may provide a rational
means for studying these systems and developing therapeutics and treatments for them, but
again, further studies on many more systems would be necessary before any such trends can be
declared.

7.0 FUTURE WORK

In light of the observations summarized in Table 47, it would be prudent and interesting
to test further cases that fall into one of the three general classes outlined. Do all one-chain
protein systems whose mutants exhibit acquired secondary structure have the mutant strain
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favored with higher Lennard-Jones and Coulombic values? Will such systems always have their
biological function impaired by the mutation(s)? These are questions which can be undertaken
as a direct “spin-off” from the results of the research reported in this work.

Additionally, one can extend further studies that make use of dynamic molecular
simulations and models to further investigate why the observations reported in this work are so
in the first place. With that research question in mind, it is important to remember that although
OpenContact© is a powerful tool to begin dissecting and investigating proteins, the results it
renders are purely from a static paradigm that do not take protein dynamics into consideration.
As has been reported for proteins such as p53, many systems’ biological activity rely on the
ability to open up to accommodate ligands. Unfortunately, one can miss out on a lot of these
conformational changes when dynamic considerations are neglected.

Lastly, now that theoretical work has been conducted on the select systems discussed in
this paper, perhaps the next level of inquiry could involve devising methods to detect these
systems in vivo. Perhaps a protocol that makes use of bio-mimetic peptides or aptamers can be
developed to indicate if these aberrant proteins are present, and even to indicate the degree of
aberrancy (a mutated p53 binds poorly to its ligand, this is not necessarily a guarantee of no
binding whatsoever). In short, novel, additional technologies can potentially be developed that
may advantage of any substantiated trends observed in later studies.
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APPENDIX A

Table A1 (pdb structure file anatomy):
1
ATOM
ATOM
ATOM
ATOM

2
7
8
9
10

3
N
CA
C
O

4
PRO
PRO
PRO
PRO

5
A
A
A
A

6
11
11
11
11

7
36.535
35.653
36.326
35.659

Fig. A1: Information section of a typical pdb file
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8
13.092
12.829
12.719
12.367

9
36.537
35.409
34.040
33.077

10
1.00
1.00
1.00
1.00

11
32.680
31.150
29.600
28.290

12
N
C
C
O

Fig. A2: Coordinate and atom data section (what DS Viewer Pro plots)

Fig. A3: Flat ribbon transthyretin with
overlaid atoms shown in wire-frame
schematic
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Fig. A4: Transthyretin in wire schema

Fig. A5: Transthyretin in stick schema

Fig. A6: Transthyretin in line ribbon schema

Fig. A7: Transthyretin in schematic schema
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Fig. A8: Tetramer of transthyretin

Fig. A9: Dimer of transthyretin

(biologically active tetramer)

Fig. A10: Mutated residues hi-lighted in
transthyretin
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Fig. A11: Mutated residues hi-lighted in
SOD1
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APPENDIX B

B1:
p53 Symmettry:
A-B

C-D

A-C

B-D

A-D

B-C
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B2:
Huntingtin Symmetry:
A-B

A-C

B-C

B3:
Transthyretin:

B4:
SOD1:
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B5:
DHFR:

B6:
HRAS:
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